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PREFACE 
 
This document represents a summary of medical and scientific evaluations conducted aboard the 
C-9 and other NASA-sponsored aircraft from June 2008 to June 2009. Included is a general 
overview of investigations manifested and coordinated by the Human Adaptation and Counter-
measures Division. A collection of brief reports that describe tests conducted aboard the NASA-
sponsored aircraft follows the overview. Principal investigators and test engineers contributed 
significantly to the content of the report, describing their particular experiment or hardware 
evaluation. Although this document follows general guidelines, each report format may vary to 
accommodate differences in experiment design and procedures. This document concludes with 
an appendix that provides background information concerning the Reduced Gravity Program. 
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Overview of Reduced-gravity Flight Activities  
Sponsored by the Human Adaptation and Countermeasures Division 
As a summary for the year, 7 weeks were specifically reserved for flights sponsored by the 
Human Adaptation and Countermeasures Division (HACD) from June 2008 to June 2009. In 
addition, we were able to obtain seating during 5 weeks for funded customers alongside Educa-
tion Outreach Program participants. A total of 35 flights with approximately 40 parabolas per 
flight were completed. The average duration of each flight was 2 hours. The Reduced Gravity 
coordinator assisted principal investigators and test engineers of 26 different experiments and 
hardware evaluations in meeting the necessary requirements for flying aboard the C-9 or other 
NASA-sponsored aircraft and in obtaining the required seating and floor space. HACD customers 
purchased a total of 374 seats. The number of seats supported and number of different tests flown 
by flight week are provided below: 
 
Flight Week Seats No. Tests 
Flown 
Sponsor 
2008    
June 24–25  5 1 Education Outreach Program 
July 17–18  8 2 Education Outreach Program 
July 22–25  25 3 HACD 
August 29  5 1 HACD 
September 9–10  12 2 HACD 
November 21  8 4 HACD 
December 9–12, 17  108 1 HACD 
2009    
January 13–16  29 6 Education Outreach Program/HACD 
January 13  18 1 HACD 
February 24–17  26 3 Education Outreach Program/HACD 
March 4, 5, 10–13, 27  126 1 HACD 
March 31–April 1  4 1 Education Outreach Program 
 
Support was provided to the Education Outreach Program during weeks in June and July 2008 as 
well as in January, February, March, and April 2009 to undergraduate students and educators 
from participating universities or middle and high schools. A large ground crew from the 
respective academic institution supported the in-flight experiments. 
 
Other HACD-sponsored flight opportunities are scheduled for weeks during August and 
September 2009. Additional flights will be added throughout the remainder of calendar year 2009 
to accommodate customers as needs arise. 
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GOAL 
The proposed experiment will test the phenomena of capillary fingering and viscous fingering in 
a 2-phase immiscible flow under the conditions of microgravity and hypergravity. 
 
INTRODUCTION 
The term capillary fingering refers to the fingering created when the initial velocity of injection is 
small and capillary forces are more dominant than viscous forces. These fingers tend to be 
smaller and wider than those produced by viscous fingering. In comparison, viscous fingering 
occurs when a less viscous fluid is driven at high velocity through a more viscous defending 
fluid. The term “viscous fingering” refers to the instabilities at the interface of a 2-fluid flow 
(Homsy, 1987). While the major driving force for viscous fingering is difference in viscosity, other 
forces, such as gravity and surface tension, have influence on the propagation of the fingers 
(Homsy, 1987). Although there are different types of fingering, the categories considered here are 
primarily viscous and capillary. The given experiment studied this phenomenon under conditions 
of variable gravity.  
Viscous fingering was first studied by Hill in 1952. A 1-dimensional analysis was performed by 
having a gravitationally driven vertical flow. Another way to think of a 1-dimensional flow is a 
single line or slice of fluid. Gravi ty and viscous-stabilizing flows were investigated. Another 
early development was by Chouke et al. in 1959. Chouke was the first scientist to include surface 
tension effects. He used 1-dimensional flows to find equations relating viscosity, surface tension, 
velocity, and gravi ty to the viscous fingering phenomenon. In 1958, Saffman and Taylor also 
found similar results (Homsy, 1987). Viscous fingering can be studied through various methods 
or geometries of injection and growth patterns. The most commonly investigated are radial 
propagation, a 5-point pattern with a source in the middle of a square with sinks on all 4 corners, 
and, as will be studied here, the 2-dimensional linear case. 
The injection of a fluid with lower viscosity into one with higher viscosity can commonly occur 
in technological applications. For instance, the insertion of air into water and oil into water are 
both common fluid pairs that can potentially produce viscous fingering. A better grasp of the 
physics governing the development of fingering patterns will help to control the fluid behavior in 
such applications. For example, changes in fuel injection can yield better combustion efficiency. 
The fuel injected can be controlled and engineered so there is a maximum uniformity mixing and 
atomization, allowing the combustors in jet engines to become more environmentally friendly. 
The process also can be used to describe the propagation of a flame, which could be instrumental 
in subduing fires in microgravity environments. As a flame expands, it takes on a fingering 
profile similar to those in the proposed experiment. 
 
There also can be an improvement in the efficiency of carbon dioxide sequestration, and the 
secondary extraction of materials from the earth, such as oil, can be optimized. More specifically, 
after the majority of oil is drilled from the earth, this secondary extraction process is used. The 
process of injecting carbon dioxide into the earth (which can be analyzed as a porous medium in 
which carbon dioxide flows through and disperses into viscous fingering) is commonly used to 
extract oil around a drill site (Saffman, 1986). As more information is developed about the 
fingering patterns, we can better answer many questions, such as (1) what will happen to the 
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carbon dioxide underground over time, and (2) are there small fingers of oil that are mixed into 
the sand and not extracted? 
 
In the future, there are plans for lunar mining. This secondary extraction process could also be 
used to extract minerals from the moon more effectively, where gravitational levels are about 1/6 
that of Earth gravity. Not only can this process be used for extracting minerals, but also possibly 
to control the underground storage of materials for a lunar space station. If technology allows, 
one day there could be mining on an asteroid as well. 
 
In the context of these applications, it is beneficial to study the fractal behavior of the fingering 
patterns in flipped Hele-Shaw Cell (HSC)-PM and HSC, and the injection HSC. It was hypoth-
esized that the flow patterns created at the interface in both the flipped HSC and HSC-PM would 
be similar given that the equations that govern both flows are analogous. Within the flipped HSC 
and HSC-PM, at higher viscosity ratios, the number and dispersion of capillary fingers were hy-
pothesized to increase. During microgravity, the 2 fluids within the flipped HSC and HSC-PM 
should not have displaced one another. However, if capillary fingers were created, it would have 
been due to forces other than gravity. Within the injection HSC, viscous fingering, as opposed to 
capillary fingering, was hypothesized to occur. Lastly, increasing the injection flow rate was 
assumed to create a greater number and dispersion of the viscous fingers. 
 
The given experiment involved 2 major components. The first part included 2 pairs of HSCs that 
were flipped about a common axis to analyze the behavior of possible capillary fingering for 
varying levels of gravity. The second part of the experiment consisted of a low-viscosity fluid 
injected into a high-viscosity fluid within an HSC. The goal of this part of the experiment was to 
simulate the flow through a 2-dimensional porous medium and to study the behavior of viscous 
fingering in varying gravity levels. 
 
The first part of this experiment involved 2 sets of closed HSC pairs with 1 HSC in each set 
containing a porous medium. These were used to study the propagation of fingers, expected to be 
driven by capillary forces, in a closed 2-immiscible-fluid system without injection. The propa-
gation of fluids through one another was based on a buoyancy force due to the 2 different fluid 
densities. In this portion, there were 2 different test pairs. Each test pair consisted of an HSC and 
an HSC-PM. Within each set, both the HSC-PM and the HSC contained identical fluid viscosity 
ratios. However, the 2 different HSC test pairs had different fluid-viscosity ratios. During the test 
period, the flows within each set were assumed to have similar patterns. 
 
An additional objective for the first part of the experiment was to investigate the flow during 
hypergravity. During the pullout when gravity increased from near zero to nearly 2 G, the 
exchanging of liquids (the denser liquid falling towards the bottom) was expected to create a 
viscous fingering pattern. As the gravitational force increased, this fingering pattern was 
predicted to occur at a faster rate and with longer fingers. The team also predicted that with a 
higher viscosity ratio, the amount and dispersion of fingers would increase. 
 
Viscous fingering, which was analyzed in the second portion of the proposed experiment, 
commonly occurs in 3-dimensional porous media, such as when water is absorbed in a sponge or 
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when carbon dioxide is injected into an oil field to enhance oil recovery. The 3-dimensional 
phenomenon is complex to analyze due to the complexity of the geometry and the governing 
equations. In addition, because of the small pore sizes and opaque nature of the 3-dimensional 
porous media, it is quite difficult to obtain experimental data. Sir Geoffrey Taylor (1958) 
overcame this dilemma in 1956 when he discovered that the flow through a porous medium could 
be modeled by flow through an HSC, and that the equations that govern both are similar 
(Saffman, 1986). 
 
The WVU Microgravity Research Team investigated this injection flow in the second part of the 
experiment in hopes of improving knowledge of how viscous fingering affects flow patterns in 
porous media for varying gravity levels. The team predicted to observe viscous fingering, as 
opposed to capillary fingering, and also the development of fractal patterns at higher injection 
rates within the injection HSC. Lovoll et al. (1983) state that fast displacements can cause a fract-
al pattern to develop in the flow. The team suspected that microgravity conditions would cause 
the fingering patterns to be more sporadic as the propagation had one less force (gravity) 
governing it. As seen from equations above, the pressure drop in the flow was also expected to be 
negative as the factor, G, would be zero. 
 
Another objective of both experiments was to describe the flow behavior qualitatively. Fingering 
patterns depend on many factors, some of which were measured in this experiment. Finger 
patterns propagate in different patterns. Saffman and Taylor (1958) first found that a single finger 
dominates the flow because of what they called shielding. They explained shielding as the ten-
dency of a finger to grow in the direction of the pressure gradient. A finger that is larger is more 
apt to grow and, thus, shield its neighbors from growing, causing the instabilities to get larger as 
time proceeds. Surface tension acting at the tips of the fingers also has a great deal to do with 
how they spread. As the surface tension decreases, the once-steady finger becomes unstable 
because of the area the finger now covers. This finger then splits at the tip and the new, smaller 
fingers are stable. One will shield the other, and then eventually will have to tip-split as well. 
Saffman (1986) found that as a finger width approached one-half of the total width of the test 
section, the finger engaged in side-splitting rather than tip-splitting (Homsy, 1987). The pattern 
of shielding then tip-splitting and repeating may be a form of fractal growth. Fractals are patterns 
in nature that continue as the frame or view is reduced until it becomes infinitesimal, or behaves 
the same at any scale. 
 
METHODS/RESULTS 
To come to a final experiment apparatus, the West Virginia University Microgravity Research 
Team attempted many different designs for each of the systems involved in the experiment. 
These include the HSC design, the porous media choice, the mechanism to flip the capillary-driven 
HSCs, the injection system used to test the viscosity driven HSCs, and the injection flow rate 
control. 
 
The first and most important subsystem of the experiment was the HSC design. Many hours were 
spent brainstorming, constructing, and testing different HSC ideas to achieve the best results 
possible for the experiment. The materials, dimensions, and adhesives that were involved all 
needed to be considered when determining the best design for the HSC. Glass, LEXAN®, and 
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Plexiglas® were tested, and Plexiglas® was chosen for its weight, durability, and the fact that it is 
hydrophobic. The thickness of outside plates of Plexiglas® used was 0.25 in. Several sizes of 
HSCs were considered, and a final size was chosen based on the strength needed for the Plexiglas® 
sides and viewing of fingers. The flipped HSCs were 6 in×8 in on the outside, 0.5-in borders and 
a gap of 0.0625 in for the test area. The injection HSCs were 5.5 in×11.5 in on the outside with 
the same 0.5-in borders, and a gap of 0.062 in. This small gap created an environment in which 
the fluids could interact with one another in a constant area. Designing the gap was a tricky 
process, because it was imperative that the gap remain sealed. To make this gap, the team tried 
using a rubber gasket as a seal between 2 compressed Plexiglas® plates but still had leakage. The 
team then tried different adhesives and a thin frame-like Plexiglas® sheet to make this gap. 
Finally, the team used acrylic glue, which was satisfactory in sealing the HSC. For the flipped 
HSCs, small holes were placed in opposite corners to fill and drain the HSCs when appropriate. 
Injection HSCs had 1 hole specially made at the top for injection and 3 holes at the bottom for 
drainage. 
 
Porous media were researched, and many different options were purchased. BBs, buckshot, 
sewing beads, and acrylic spheres were considered. The acrylic spheres were chosen for their size 
and hydrophobic nature. These spheres had a diameter of 0.0625 in.  
 
A flipping mechanism was needed to test capillary fingering. The mechanism design consisted of 
a hand crank used to flip a central axis connected to all 4 flipped HSCs. This hand crank could be 
used from the outside by an operator and held the HSCs at 180-degree intervals. A stepper motor 
was considered for automation, but not integrated due to unnecessary complication and time 
constraints. 
 
For the injection subsystem, the team chose to use an air compressor plug to inject air through an 
inflatable ball while keeping the HSC sealed. The excess fluid pushed down by the air would 
travel up a manometer-like pressure equalization tube (PET) in microgravity. This would then 
refill the HSC when reentering gravity. This was very different from the originally designed 
system and other evolving ideas. Such systems included the use of fluid-separating membranes, 
multiple fluid tanks to refill the HSC, multiple injection sites, and expanding bladders to relieve 
pressure and control excess fluid. 
 
Varying the flow rate was achieved through the use of a variable power supply. By changing the 
voltage of the power supply, the rate of injection from the air compressor could be controlled. 
The voltage range was from 0 volts to 17.5 volts. A fully constructed experiment setup follows. 
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Side view of completed experiment. 
 
After construction, the experiment was flown aboard the C-9 aircraft. MRT 7 was unsuccessful 
in collecting video recordings on either flight day (reasons and solutions to these problems are 
listed in the conclusions section to help prevent this from happening to future teams). The team’s 
only data from the plane were from member observations during flight. 
 
The compressors did not release any air while in flight for either day, thus there were no 
observations made for the injection HSCs. Some things were taken from the flipped HSCs, even 
though it was very hard for an observer to see the HSCs from the outside because of the 
enclosure constructed to help with lighting. On the first day, flyers saw little action during 
microgravity in the flipped HSCs, as expected. In the water and air HSC with no porous media, 
there were mixtures of air pockets and water globules floating throughout the HSC. The oil and 
glycerin HSC had little instabilities, but did have a slightly curved interface. Because of lighting, 
no observations could be made in either porous-media HSC. The second day, flyers saw similar 
results. The water and air with no porous media were observed to be stable with no fingers and 
only slight instabilities probably caused by plane vibrations. The oil and glycerin with no porous 
media showed similar results. The water and air with porous media did have very small fingers 
during microgravity, probably either residual from the constant flipping or driven by the surface 
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tension of the bead pack. Once again, no observations could be made from the oil and glycerin 
with porous media HSC because of poor lighting. The second day, flyers also attempted to 
observe the HSCs in hypergravity conditions. The water and air with no porous media fell 
extremely fast and no fingers were seen by the naked eye. The oil and glycerin with no porous 
media did have some long-thin fingers with almost no tip-splitting. The water and air with porous 
media had many fingers that moved quickly and branched off in many directions. Finally, the oil 
and glycerin with porous media could not be observed, again because of poor lighting. 
 
For some visual data, the team did a ground run using the same fluids, injection rates, and 
equipment that were used for the experiment in microgravity. Flipped HSCs showed hypothe-
sized results. The water and air with no porous media interaction moved very quickly in this 1-G 
environment, and swirled instead of fingered. The water and air with porous media interaction 
had some slow individual fingers. The oil and glycerin with no porous media also showed some 
fingering. The oil and glycerin with porous media was very hard to see, but had some fingers. 
These fingers are known to be capillary fingers, because the capillary numbers of these inter-
actions are very low. This is because the velocities were zero to start and very low even when 
well into the interaction. 
 
From this ground run, many observations were made pertaining to the relationship between the 
flow rate and finger geometry or fluid and finger geometry in the injection HSCs. The voltage 
was varied from 5 volts to 17.5 volts in 2.5-volt increments. From the video, it was observed that 
as voltage increased in the oil and air fluid pair HSC, the finger length increased and finger width 
decreased. There was also much more tip-splitting and side-branching fingers. In some rare cases 
at higher voltages, multiple fingers were observed. At higher voltages, finger growth would in-
vert and go back toward the source of the air. Increased flow rate displaces the defending fluid 
more rapidly, which allows the fingers produced by the invading fluid to be longer and narrower. 
This increased speed of finger propagation also catalyzes the effect of tip-splitting of these 
narrowed fingers. 
 
In the HSC with water as the defending fluid, the findings were almost completely opposite. This 
interface was much more stable, in general, with most of the instabilities on the interface being 
prevalent but with no large fingering. At smaller injection rates, fingers did occur, but, at larger 
rates, only a “saw tooth” effect on a relatively flat interface occurred. The “saw tooth” effect 
could have been caused by inherent vibrations from the mechanical motion of the air compressor. 
This effect was more apparent in the water HSC, because the defending fluid was less viscous, 
causing the defending fluid to fill the void caused by the injected air more quickly, thus 
producing fewer long fingers. 
 
Individual injection runs were analyzed in more depth using the fluid properties, the ground run 
video, and dimensionless numbers. In the first set of data for the oil and air injection, the voltage 
was set at 5 volts. This resulted in a finger velocity of 0.297 meters per second. This velocity was 
found by taking the time for finger growth and dividing by the average finger length. This method 
is an approximation, as the video software used did not allow video to be viewed frame by frame 
and there was no zoom availability. In addition to this velocity, values were researched for the 
viscosity of the invading fluid (air) and the surface tension between the 2 fluids (air and oil). 
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These values were 1.82×10-5 Pascal-seconds and 0.047 Newtons per meter. These were used to 
find the capillary number, which was 1.150×10-4. This is larger than the reference value of 10-5 
meaning that this interaction was driven by viscous forces. The viscosity ratio was then calcula-
ted using a value of 4.425×10-3 Pascal-seconds for the viscosity of oil. This ratio was found to be 
243.13. Visual inspection showed a tip split into 2 fingers and 2 main-side branches emanating 
from the main finger. 
 
Another injection run was analyzed, this one at 12.5 volts. The velocity was found to be 0.521 
meters per second and the capillary number was 2.017×10-4. This also was larger than the 
reference value and, thus, driven by viscous forces. Of course, the viscosity ratio was the same. 
Visual inspection showed 1 main finger with a smaller, secondary finger. The main finger had 17 
side branches and 1 tip split. 
 
The same voltages were analyzed for the water and air injection. With the viscosity of air at  
1.82×10-5 Pascal-seconds and the surface tension between the water and air equaling 0.07286 
Newtons per meter, the capillary number can be could be calculated using the velocity. Since the 
velocity was 0.1099 meters per second for the 5-volt run, the capillary number is 2.745×10-5. For 
the 15-volt run, the velocity was 0.3533 meters per second and the capillary number was 
8.825×10-5. These numbers are only slightly larger than the reference value, so theory says that 
these interactions show a stable interface, which was observed. The flow was driven by capillary 
and viscous forces, so a viscosity ratio needed to be calculated. The viscosity of water is known 
to be 1×10-3
 
Pascal-seconds, meaning the viscosity ratio was 54.95. 
 
When comparing the 2 separate-fluid interactions, many interesting numerical observations were 
made. The velocity was found to be slower in the air-into-water injection. This was due to the air 
being distributed evenly across the cell in this injection instead of concentrated in 1-slim finger, 
as in the air into oil injection. The capillary numbers were larger in the air-into-oil injection, 
which was anticipated because this interaction was known to be driven by viscous forces, 
whereas the “air-into-water” injection numbers were near the boundary. Finally, as the viscosity 
ratio increased, the fingering complexity increased. This was consistent with theory. 
 
In comparing the varying voltages, other similar numerical observations were made. In the air-
into-oil injection as voltage was increased, velocity increased, and the capillary number and 
fingering thus increased. This was because this injection was driven by capillary forces, and these 
forces were greater with the increased velocity. The opposite occurred in the air-into-water injec-
tion. As the velocity was increased, the capillary number increased, but the fingering decreased 
and the flow was more uniform. This is because as capillary fingering turned to viscous 
fingering, a smooth interface was observed and the increased velocity brought the flow closer to 
this boundary. 
 
CONCLUSION 
There was no successful video data collection for either of the 2 flight days, due to technical 
difficulties. While there was a lack of data received during flight by WVU MRT 7, the team did 
learn many valuable lessons that could be readily applied if this experiment were chosen for re-
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flight. The issues that arose can mainly be attributed to lack of experience and unforeseen 
electrical/mechanical problems; most, if not all, of these have very simple solutions. 
 
The first and foremost problem occurred within the data recording interface. Four cameras were 
used for the experiment: including 2 standard-definition JVC camcorders and 2 high-definition 
JVC camcorders. JVC uses a battery conservation safeguard that automatically shuts down the 
camera when the liquid crystal display (LCD) viewfinder is closed. Whether this function is good 
or bad, it is a very strange function and, unfortunately, the team was not expecting this, resulting 
in zero data from the first flight day. On the second day, the viewfinders were kept open, but, 
unfortunately, the batteries ran out on all camcorders prior to the first parabola. In hindsight, this 
catastrophe could be easily have been prevented by using extended-life batteries, which will be 
purchased for future camera use. Alternatively, the 2 newer, high-definition cameras can be 
operated with alternating current (AC) power provided from the power strip on the aircraft. 
However this function is unavailable for the 2 older, standard-definition cameras.  
 
The next issue, which dealt with the fluid reactions, could be avoided with a more exact 
assembly. The HSC containing the porous medium had a gap that was slightly larger than the 
diameter of the beads used to form the porous medium. This caused the beads to arrange in 
approximately 1.5 layers instead of only 1 layer. This created extra space and irregularities in the 
bead pack, as shown following. 
 
By observation, the team was also led to believe the beads were close enough so the surface 
tension between the fluid and the bead material drove the flow more than the fluid interaction, 
which was not the goal of the experiment. 
 
These problems could be solved a number of ways, including the use of a mill for construction of 
all HSCs. Using a mill will ensure, to a very small tolerance, that the HSCs will be just wide 
enough to fit the beads, thus leaving no gaps between the beads and the glass. Another approach 
would be to have porous-medium HSCs with machined cylinders through the test area instead of 
a bead pack. An example of an ideal bead pack follows. 
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This would definitely eliminate the double stacks and gaps, and possibly eliminate most of the 
surface-tension-driven flow. The only negative of this idea is the feasibility. If it can be made, it 
is a much better approach. 
 
There was another problem with fluid reaction, specifically the visual aspect. The fluid pair 
choice of glycerin and oil seems to be the root of the problem. The colors of these 2 fluids were 
so close that it was hard to distinguish the interface. Thus, if 1 fluid could be dyed, such as water 
with food coloring with a dye that will not change its properties significantly; this would be an 
easy solution. If not, new fluid pairs must be chosen. The reaction between this pair was also 
very slow, and the time during microgravity and hypergravity was not sufficient for a complete 
reaction to occur. In addition, a numerical value for surface tension between the 2 fluids could 
not be located, so some theoretical numbers could not be calculated. Overall, a new fluid pair 
would be the easiest solution. 
 
Finally, the most intriguing and unforeseen problem was with the compressors. Both flight days, 
just prior to flight, the air compressors were tested while in the plane and were functional. Yet, at 
altitude, they did not work. They were connected to a variable power supply and the range of volt-
ages and currents (0 amps to 10 amps and 0 volts to 18 volts) were tried on both days, but to no 
avail. The team investigated this and found that the only electrical requirement for high-altitude 
compressors was less power. A website, which was found by the team, said, “The efficiency of 
air compression depends on air temperature, atmospheric pressure, and relative humidity. The 
rating of an air compressor therefore depends on ambient conditions. This aspect should be taken 
in to account if an air compressor is used in very cold weather, very wet weather or at a high 
altitude.” With the compressors working on the ground, the team knew that there was enough 
power in the variable power source, thus less power could be achieved and was tried in flight. 
The team then tested many different models of air compressors in a pressure chamber at WVU, 
in the Mechanical and Aerospace Engineering Department, to see whether the change in pressure 
with altitude was the source of the problem. Compressors were individually placed in the 
chamber and connected to a 12.97-volt, 1-amp battery and turned on. The pressure inside the 
chamber was then lowered to near-vacuum, and observations were recorded. In each case, the 
compressors worked but at a slightly lower flow rate. The team thought this pressure difference 
was the root of the problem but through this test that theory was disproved. At the time of 
submission, the team is still investigating why this failure occurred. One possibility is the plane’s 
power was sufficient while grounded, with power coming from the ground, yet not sufficient 
while in flight. The easiest solution would be not to use air compressors and instead use a more 
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simple air injection system. This could be a syringe primed with air and mechanically plunged 
using some sort of motor to ensure injection rate consistency. The rest of the system could be the 
same with the air release tube at the top and pressure equalization tubing. The syringe would 
have an air reserve with a check valve to reset. A pressure vessel could also be an option, but the 
safety of the team and other members aboard the flight would have to be considered. 
 
Even with no video data of the experiment in microgravity, the team got valuable flight 
experience with this experiment. If chosen for re-flight, the experiment could be greatly 
improved and valuable data could be obtained from it. This team’s experience will greatly 
improve the success of future teams. 
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VIDEO 
• Zero-G flight week 6/23–6/27/08, Master #: 738978 
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Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
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ecalandr@mix.wvu.edu 
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GOAL 
The inhalation and deposition of small particles in the lungs is a health concern here on Earth and 
future space travelers risk detrimental health consequences from particle inhalation. Because 
gravity affects the deposition of particles in the lung, in microgravity or in the reduced gravity of 
the Moon and Mars inhaled particles are left in suspension in the airways, and can be transported 
deeper into the lung where they reach the sensitive alveolar region. On the Moon and Mars, it is 
believed that much of the dust is highly reactive, which may exacerbate its potential for lung 
damage. Because it is electrostatically charged, lunar and Martian dust sticks to spacesuits and 
could be tracked into habitats and subsequently inhaled. 
 
OBJECTIVES 
The deposition of aerosols from the environment in the lung presents a health risk. For particles 
larger than 0.5 micron, such deposition is strongly influenced by gravitational sedimentation. In 
microgravity, deposition by gravitational sedimentation is absent, and, as a consequence, airway 
particle concentrations are higher than in 1 G, thus enhancing aerosol transport to the alveolar 
region of the lung. The presence of previously unaccounted for complex mixing patterns in the 
periphery of the lung, combined with high alveolar aerosol concentrations, results in high depo-
sition in this sensitive region of the lung in microgravity. Similar effects are expected in the 
fractional gravity environments of the Moon and Mars. 
 
The dust on the surface of Mars is highly oxidative in nature, due to the ultraviolet (UV) 
environment on the surface. Mars dust is also electrostatically charged, and so will tend to stick 
to the outside of spacesuits and be tracked into habitats. The lung, with its huge exposed surface 
area, is highly vulnerable to adverse effects resulting from exposure to Mars dust. 
 
We propose a multifaceted approach involving human and animal experiments, combined with 
sophisticated modeling, to provide a path to assessing the health risk of dust exposure in habitats 
on both the Moon and Mars, addressing risk No. 7 in the Bioastronautics Critical Path Roadmap. 
Such an assessment has profound implications on the degree of engineering (and, thus, cost) that 
will be required to limit the risk of such exposure to the inhabitants of these habitats. We will 
address the following hypotheses and objectives: 
 
1. That total aerosol deposition in the human lung in fractional gravity will be higher than 
predicted by existing models (as is the case in microgravity), and that a higher-than-predicted 
alveolar deposition will result in these circumstances. Using the NASA Microgravity Research 
Aircraft, we will non-invasively measure both the total and the regional deposition of inert 
particles (0.5 microns to 2 microns) in humans in fractional-G corresponding to that on the 
surface of the Moon and Mars. 
2. That aerosol deposition in the lungs of spontaneously breathing rats in fractional-G will be 
more peripheral (closer to the alveoli) than in 1 G. We will expose spontaneously breathing 
rats to fluorescently and magnetically labeled particles of varying sizes (between 0.5 microns 
and 2 microns) in 1 G, and in fractional-G corresponding to surface of the Moon and Mars, 
and measure the specific sites of regional deposition in the lungs using both fluorescent 
confocal microscopy and magnetic resonance imaging (MRI) techniques. 
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3. We will couple existing sophisticated computational fluid dynamics (CFD) models of the 
upper airways of humans to our model of the alveolar region of the lung to predict aerosol 
deposition under conditions matching those of the experiments performed in humans. In rats, 
we will use detailed 3-dimensional images of the rat bronchial tree to develop an upper 
airway CFD model that, used in conjunction with an appropriately scaled alveolar model, will 
predict aerosol deposition under conditions matching those of the experiments performed in 
rats. 
 
METHODS AND MATERIALS 
Human Studies in Fractional-G 
In the past we have measured both total and regional aerosol deposition in humans in 1 G and in 
microgravity (see Preliminary Data). The results of those studies highlighted the nonlinear nature 
of aerosol deposition of small (~1 µm) particles as a function of G-level (Darquenne et al., 1997). 
Thus, to accurately determine particle deposition in fractional-G, direct measurements are 
required. 
 
Total Deposition 
Protocol overview: We will measure total deposition of 0.5-µm and 1-µm particles in the lungs of 
subjects in 1 G and at fractional-G levels corresponding to the surface of the Moon and Mars 
(termed 1/6 G and 1/3 G for the sake of convenience). Total deposition will be measured during 
controlled tidal breathing, and, as was the case in our previous studies in microgravity (Darquenne 
et al., 1997), we will select data during stable G-level periods after allowing sufficient time at that 
G-level for deposition to stabilize (2 to 3 breaths). We will study 6 subjects. 
 
Equipment: Deposition data will be collected by using equipment that is similar to that used in a 
previous study (Darquenne et al., 1997). The subject breathes from a reservoir through a non-
rebreathing valve. Aerosol concentration and flow rate are measured at the mouth using a 
photometer and a pneumotachograph, respectively. A diffusion dryer is located between the 
photometer and the mouthpiece. The system is heated to body temperature to prevent water 
condensation. Data are recorded on a laptop personal computer (PC) equipped with a data 
acquisition subsystem. 
 
Central and Alveolar Deposition (SA1b) 
Protocol overview: The proposed protocol will be the same as that used in our previous studies of 
bolus deposition and dispersion (Darquenne et al., 2000, 1998, 1999). The subject will perform 
the standardized maneuver described in Preliminary Studies, and a 70-mL bolus will be inserted 
in the inspiration at one of the preselected penetration volumes (Vp) using the equipment shown 
in the Facilities and Equipment section. During the subsequent expiration, the exhaled bolus will 
be recorded. 
 
We will measure deposition, dispersion (change in bolus half-width), and bolus mode shift. We 
can designate a volume below end inspiration for the bolus (the penetration volume, Vp), and 
propose to measure aerosol bolus parameters at each of 3 Vp (200 mL, 500 mL, and 1,200 mL). 
We will use 2 particle sizes (0.5 µm and 1 µm) at 1 G and in 1/6 G. As was the case before, 
measurements will be performed in triplicate on a total of 6 subjects. 
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Equipment: The equipment, which will be the same as that used for previous studies, uses the 
same photometer and pneumotachograph system used in the total deposition studies. In brief, a 
pneumatically controlled sliding valve allows the subject to breathe either filtered room air, or 
allows inspiration through a tube prefilled with a bolus of aerosol. By actuating the sliding valve 
at the appropriate point during inspiration, the bolus can be delivered at any desired penetration 
volume with an accuracy of ±100 mL. A full description can be found in previous publications 
(Darquenne et al., 1998). 
 
Rat Studies in Fractional-G 
We propose to determine the degree of deposition and the location of inhaled particles in the 
lungs of spontaneously breathing rats, and compare the deposition patterns in 1 G and in 
fractional-G levels corresponding to the surface of the Moon and Mars. Our hypothesis is that in 
the fractional-G environments, total deposition may be somewhat reduced, but those particles 
that do deposit will do so more peripherally. In humans, more peripheral deposition results in 
particles avoiding the mucociliary system and, in the case of oxidative particles, could increase 
oxidative damage to the lung. 
 
By performing these studies in rats, we can subsequently use anatomical and state-of-the-art 
imaging techniques to determine the exact site and degree of deposition, providing otherwise 
unavailable validation for the CFD models. We expect to be able to experimentally demonstrate 
alterations in the heterogeneity of particle deposition between G-levels. 
 
Protocol: We propose to expose on the NASA Microgravity Research Aircraft spontaneously 
breathing, restrained rats to fluorescent-labeled and MRI-labeled particles during periods of 
fractional-G corresponding to the surface of the Moon and Mars. During 1 G and during the 
hyper-G phase of parabolic flight, the animals will breathe filtered air, and while the aircraft is in 
fractional-G they will be exposed to particle-laden air for head-only particle exposure for a cu-
mulative exposure period of approximately 20 minutes. At the completion of the flight, the 
animals will be euthanized and the lungs preserved. The lungs will be returned to San Diego for 
MRI of particle location, and for slicing and confocal microscopy of fluorescent particle location 
(see below). We propose to use 3 different particle sizes (0.5 µm, 1 µm, and 2 µm), matching 
those used in the human studies (see above). We will require 2 flights per size and G-level (10 
rats per condition) for a total of 12 flights. 
 
Exposure techniques: Five rats (adult male Wistar, with a body weight in the range 200 g to 250 
g) will be simultaneously restrained in head-out plastic cones (Sweeney et al., 1991) in individual 
sealed plethysmograph chambers. When the animal breathes, changes in box pressure occur as 
inspired air is warmed and humidified in the respiratory tract, allowing the calculation of tidal 
volume and breathing frequency (Jacky, 1978, 1980). An identical reference chamber will be 
used, and differential pressure between the plethysmograph and the reference chamber will be 
measured (Jacky, 1978, 1980). This will eliminate difficulties associated with changes in cabin 
pressure in the aircraft. The chambers will be ventilated continuously by drawing either filtered 
cabin air or particle-laden air through them at approximately 250 mL/min (Sweeney et al., 1991). 
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The inlet path for the ventilation will be such that it impinges directly onto the nose region of the 
restrained rats. This arrangement will allow us to rapidly switch the inlet flow between filtered 
(particle-free) air and particle-laden air drawn from a reservoir into which particles in suspension 
have been aerosolized during the period of hypergravity immediately preceding the fractional-G 
parabola. During 1 G and during the hyper-G phase of parabolic flight, the animals will breathe 
filtered air, and while the aircraft is in fractional-G they will be exposed to particle-laden air for 
head-only particle exposure. The fractional-G time available to us in the aircraft is about 35 
seconds to 40 seconds for 1/6 G and approximately 45 seconds to 50 seconds for 1/3 G, giving a 
cumulative exposure period of about 20 minutes assuming 30 seconds (which will be recorded) 
of fractional-G exposure time can be used per parabola. Control studies on the ground (1 G) will 
be performed after the fractional-G studies, allowing us to match the timing of the exposures to 
those that occurred during the flights (a delayed synchronous control approach). Importantly in 
the context of this proposal, Pinkerton et al. (1993) demonstrated in 1-G exposure times of 15 
minutes to 30 minutes, deposition of 1.0-µm microspheres throughout the bronchial tree and 
alveoli of spontaneously breathing rats. 
 
At the completion of the flight, the animals will be anesthetized by intraperitoneal injection of 
pentobarbital; the trachea will be cannulated and connected to a pressure source to permit setting 
of intratracheal pressure. The caudal vena cava will be cannulated, and the carotid arteries and 
veins will be cut to permit perfusion fixation. Physiologic buffered saline will first be infused for 
5 minutes to clear blood from the lungs, followed by fixative for 15 minutes as described by 
Pinkerton (1993). Intratracheal pressure will be maintained at 9 mmHg, providing for a lung 
volume approximating functional residual capacity. 
 
RESULTS/DISCUSSION 
The July 2008 flight week provided a good test of the new rat plethysmograph system. In flight, 
we obtained good breathing pattern signals and experience on dosing the animals with large-
diameter particles. Based on preliminary results, very low deposition of large (~5 micron) 
particles occurred, even in reduced gravity. 
 
The September 2008 flight week was cut short (2 flights only) as a result of Hurricane Ike. Good 
technical quality data were obtained on both days. Preliminary data show a significant deposition 
of 1-micron particles in the flight lungs. Because of the reduced flight schedule that week, a 
further week of flight is planned. 
 
In the February week, we performed an additional data collection on the human studies in which 
we studied the combined effects of reduced gravity and reduced gas density. This was outside the 
originally planned studies but was occasioned by the recent definition of the low-density atmo-
sphere for a lunar base. Studies were performed on 8 subjects with technically good results. No 
scientific results are yet available. 
 
CONCLUSION 
Reduced gravity results in a more peripheral site of deposition of fine particulate matter in the 
human lung compared to 1 G (see Darquenne et al., 2008). 
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Further conclusions from more recent studies are pending data analysis. 
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GOAL 
The goal of this experiment was to ensure that the collection of seated-height data was accurate, 
and that the subject was properly restrained to the seat with minimal gap between the subject and 
the seat pan. To test the methodology and procedures developed for the on-orbit experiment, a 
simulated microgravity evaluation was proposed. The simulated microgravity evaluation pre-
sented in this report was a precursor to the payload experiment on board the shuttle to measure 
the effect of microgravity on spinal elongation in a seated configuration. This evaluation obtained 
data to (a) ensure that the lap restraint provided sufficient restraint to eliminate any gap between 
the subject’s gluteal surface and the seat pan, and (b) document and verify that the lap restraint 
tension did not affect seated-height measurements in microgravity. 
 
OBJECTIVES 
1. To collect seated-height anthropometric data while experiencing microgravity to ensure an 
accurate seated-height measurement will be collected during the on-orbit experiment: Spinal 
Elongation and its Effects on Seated Height in a Microgravity Environment. 
2. To collect force and pressure data of how much a subject is loading the seat while restrained. 
3. To update the crew procedures and hardware design as necessary for the in-orbit experiment. 
 
METHODS AND MATERIALS 
This experiment was performed on the microgravity aircrafts C-9 and ZERO-G®. Three flights 
occurred during which approximately 50 parabolas during each flight simulated lunar and 
microgravity conditions during each flight. However, since the payload experiment will be 
performed in microgravity, it was the data from the microgravity parabolas that were of most 
interest. The data collected during these 3 flights were seated height, force data, and pressure 
data. 
 
The test setup included: the shuttle seat, a load cell plate, an X-Sensor pressure pad, an 
anthropometer, and data acquisition systems. The shuttle seat was secured to the aircraft floor 
facing the starboard side of the aircraft. Attached to the shuttle seat was a standard anthropometer 
(figure 1). For Flights 1 and 2, a standard anthropometer was attached to the seat pan and secured 
by tape to the back of the chair. However, during Flight 3, a prototype of the flight hardware an-
thropometer was used, which attached to the top of the seat back in the same manner as the head-
rest (figure 2). During all 3 flights, a load cell plate and X-Sensor pressure pad were secured to 
the seat pan of the shuttle seat. The load cell plate and X-Sensor pressure pad were connected 
through a series of cables to the data acquisition systems located on the computer rack. The load 
cell plate, or force plate, collected only the vertical force applied by the subject, and the pressure 
pad collected the pressure applied by the subject, resulting in the outline of the buttock and 
thighs. 
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Figure 1. Equipment layout during Flights 1 and 2. Figure 2. Equipment layout during Flight 3. 
 
During the simulated microgravity parabolas, the subject was seated in the shuttle seat and 
restrained for the collection of pressure, force, and seated-height data. The subject remained 
seated during several consecutive parabolas; the number of consecutive parabolas varied between 
subjects. 
 
During the first flight, only 1 restraint system was examined: 3 points of the current 5-point 
harness. The 3-point harness included the use of the crotch buckle and 2 pelvis straps. Data were 
collected for 4 subjects during Flight 1. The second flight examined multiple restraint systems: 
the 3-point harness, the 3-point harness with leg strap, the 3-point harness with leg and lap straps, 
the 3-point harness with loose buckle, and the 3-point harness with a foam insert. During the 
second flight, the 3-point harness was adjusted to wrap around the seatback support bars. Four 
subjects participated in Flight 2. However, only 2 of these subjects participated in Flight 1. To 
compare across restraints, the 3-point harness examined during Flight 1 was also examined 
during Flight 2 for those subjects who did not fly during Flight 1. The third flight, Flight 3, tested 
the prototype anthropometer assembly and the 3-point harness wrapped around the seatback 
support bars. Data were collected for 3 subjects; all 3 subjects participated in Flight 1, and 2 of 
the subjects also participated in Flight 2. 
 
Seated-height data were collected during all 3 flights for each restraint system examined. The 
seated-height data were used to validate which restraint system secured the subject to the seat pan 
with the smallest amount of variability between the measurements. To ensure minimal variability 
to the measurement, all measurers followed a standard procedure. Once in microgravity, the 
measurer ensured the subject was looking straight and lowered the tyne of the anthropometer to 
the middle of the subject’s head, ensuring proper contact with scalp of the head, and collected the 
seated-height measurement. 
Anthropometer 
Load Cell 
Plate 
Anthropometer 
 Load Cell 
Plate  
X-Sensor 
Pressure Pad 
X-Sensor 
Pressure Pad 
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RESULTS 
During all flights, seated-height measurements and pressure data were collected. During Flight 1 
and Flight 3, force data and the aircraft acceleration also were collected. However, this analysis 
will focus on the seated-height measurements collected during microgravity parabolas. 
 
Flight 1 
The ranges of seated-height measurements collected during Flight 1 varied from 1.1 cm to 5.6 
cm. The variability in the seated-height measurements indicates that the subjects were not tightly 
restrained to the seat and that the subjects were not in complete contact with the seat pan. The 
subjects also reported the lack of restraint; the subjects often felt as though their buttocks were 
floating off of the seat in microgravity, even with the lap restraint tightened as far as the restraint 
system would allow. 
 
The results from Flight 1 demonstrate that the current 3-point harness used in its nominal 
configuration was not sufficient to ensure contact between the subject and the seat pan to collect 
consistent seated-height measurements. The restraint system must restrain the subject properly so 
that the seated-height measurements are consistent. Inconsistent measurements will adversely 
affect the amount of spinal growth that is reported to the designers, which may impact crew 
safety and crew fit with the seats, suits, and vehicle after exposure to microgravity. 
 
Flight 2 
From Flight 1 it was realized that the 3-point harness in its nominal configuration was not 
sufficient to restrain the subject. As a result, other methods of restraints were explored during 
Flight 2, namely: 
 
• Flight 1 – 3-point configuration 
• Flight 1 – 3-point configuration with a foam insert under the buckle 
• A 3-point harness with a loose buckle and a Velcro® leg strap 
• Flight 2 – 3-point harness configuration 
• Flight 2 – 3-point configuration with Velcro® leg strap 
• Flight 2 – 3-point configuration with Velcro® leg and lap straps 
 
According to the seated-height measurements collected during Flight 2, the seated-height range 
verified that the Flight 2 configuration restrained the subject(s) more effectively than the Flight 1 
configuration. The greatest range in seated height for subject 1 was 0.5 cm for Flight 2 (3-point 
with leg and lap configuration) compared to 1.4 cm for Flight 1. This indicates that the subject 
was better restrained in the seat for Flight 2 than for Flight 1. For subject 2, the range decreased 
from 2.3 cm to 0.3 cm. This shows that with the modification of the restraint belts, the 
consistency increased. Looking at the 3 different types of restraints and the range of measurement 
variation, the data indicate that the addition of the leg and lap straps minimized the seated-height 
range, except for subject 1. This would signify that the addition of a leg and lap strap may be 
necessary to restrain the subject to the seat and allow for accurate seated-height measurements. 
However, when comparing the average seated-height measurements for each configuration, the 
seated-height measurements did not vary greatly. The difference in the average seated heights can 
be accounted for by the variation that occurs while collecting anthropometric measurements 
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using traditional methods; i.e., manual measurements using an anthropometer (0.6 cm). 
Therefore, based on the subjects from Flight 2, any Flight 2 restraint configuration would be 
satisfactory to collect seated-height measurements in microgravity and restrain the subject to the 
seat pan. 
 
Flight 3 
Flight 3 tested the Flight 2’s 3-point harness configuration in addition to the use of the prototype 
anthropometer to be used during shuttle missions. The prototype anthropometer attaches to the 
seatback in the same manner as the headrest. In addition to testing the 3-point harness, the 
subjects were also asked to look up, down, and straight forward to determine whether the head 
position affected the seated height. During Flight 3, it was also apparent that the operator and 
subject must work together to ensure that the restraint system is tight against the subject’s pelvis. 
Several times the restraint was not completely tight, and the subjects responded by stating that 
they were not cinched down completely and felt as if they were floating. As opposed to the first 2 
flights in which 1-seated-height measurement was collected per parabola, Flight 3 collected 
multiple seated-height measurements during a single parabola (after the first 11 parabolas). 
 
When the subjects were loosely restrained versus tightly restrained with the 3-point harness, the 
range of the seated-height measurements decreased. Subject 2’s measurement range decreased 
from 1.4 cm to 0.6 cm due to tightening of the restraint system. All 3 subjects’ seated-height 
ranges were similar when they were tightly restrained (0.6 cm, 0.6 cm, and 0.7 cm), indicating 
that when tightly restrained the variation in seated height was due to the effects of microgravity 
and the variation in collecting manual measurements. 
 
Based on the limited amount of data collected during Flight 3, in which the subjects changed 
their head orientation from looking forward, down, and up, the seated-height measurements did 
change for subject 1 and subject 2. When comparing looking forward to looking down, there was 
a greater increase in seated height for subject 1 compared to subject 2. This resulted from subject 
2 drastically looking down as opposed to subject 2 who did not drastically look down at the floor. 
This relative difference in head orientation was not seen when the subjects looked up. Therefore, 
the difference in seated heights when the subjects looked up versus looking forward was very 
small, 0.2 cm and 0.4 cm, respectively, for subjects 1 and 2. Another factor that may explain the 
small variation in seated-height values when looking up was the location on the head where the 
measurement was collected. The measurements may not have been collected from the most 
superior location on the head but, rather, from the middle of the head. From the results of looking 
down, it can be assumed that if the subjects drastically looked up and the measurement was 
collected at the most superior location on the head, the seated-height measurements would be 
affected the same as when the subjects drastically looked downward. If the seated height of the 
payload experiment were to be recorded when the subjects were not looking forward, the results 
from the study that would be given to the designers and used to update Constellation’s Human 
System Interface Requirements would be over-calculated, impacting crew safety, crew selection, 
and anthropometric requirements. 
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DISCUSSION 
Flight 1 
Two lessons learned while collecting seated-height measurements during Flight 1 were: (1) to 
make sure the subject is looking straight forward, and (2) to make sure the subject is in the center 
of the seat. Often, subjects perceived that they were looking forward but were actually looking 
slightly downwards. Also, there were times when the anthropometer was not positioned in the 
middle of the subject’s head due to that subject’s positioning on the chair. Therefore, the meas-
urer needs to instruct subjects as to how to move their torsos/heads so that the anthropometer 
measures to the middle of the top of the head. The 2 lessons learned can affect the measurement 
of seated height by providing more accurate data. Without accurate data, the impact of spinal 
elongation on seat positioning and fit may pose risks to crew safety. The effectiveness of the 
crew may be reduced due to impaired access to displays and controls, and selected crewmembers 
may not fit into seats following exposure to microgravity. The inaccurate data could also be fed 
to the designers and into the requirements for crew exploration vehicle (CEV) and future 
vehicles, habitations, and spacesuit components. 
 
Flight 2 
During this flight, the 3-point-harness-waist straps were adjusted to wrap around the seatback 
support bars; this increased the consistency in measurements and the contact between the subject 
and the seat. The subjects felt better restrained with this configuration than with the configuration 
of Flight 1. However, the average seated heights results from this flight demonstrated that 
additional straps were not necessary. Therefore, additional hardware was not needed for the on-
orbit activity. The decision was made to proceed with the Flight 2’s 3-point-harness 
configuration for on-orbit activities; wrapping the restraint belts around the seatback joint. 
 
Flight 3 
Using the prototype anthropometer during Flight 3 resulted in little variability during parabolas 
and decreased the inconsistencies of using a standard anthropometer taped to the load cell plate. 
Also, using the Flight 2’s 3-point harness configuration decreased the delta for seated height due 
to the tightening of the restraint. During Flight 3, several seated-height measurements were 
collected when the restraint was not completely tight, resulting in a greater range than when the 
restraint was pulled tight around the subject’s pelvic/waist area. The lack of tightness led to in-
consistencies within the seated-height measurements. As a result, a lesson learned from Flight 3 
is that after the subject gets in the seat and is buckled, the operator must pull the side straps as 
tight as he/she can to ensure the subject is in contact with the seat pan. 
 
Comparing the average seated height for the 3-point-harness-restraint system for all 3 flights, it 
was determined that the Flight 3 configuration improved the variability compared to Flight 1. 
Flight 2 had the smallest seated-height range but had the fewest seated-height measurements for 
each subject; subject 1 had 2 measurements, and subject 2 had 3 measurements. 
 
CONCLUSION 
In conclusion, the microgravity flights were pertinent to the spinal elongation payload 
experiment. Flight 1 verified that the current 3-point-harness system was not sufficient to provide 
adequate contact between the seat pan and the subject. Flight 1 also provided insight into some 
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possible procedural problems that may occur. The lessons learned during Flight 1 were: (1) the 
subjects often perceived that they were looking straight when they were looking slightly 
downward, and (2) the operator should confirm that the subject is in the center of the chair so 
that the anthropometer measures to the middle of the head. These lessons learned have been 
included in the crew procedures, ensuring that crewmembers are aware of these issues and that 
testers can position the subjects as necessary to achieve an accurate seated-height measurement. 
 
After learning that the current restraint system was not sufficient, 7 alternative restraint systems 
were examined during Flight 2. The results from Flight 2 indicated that a restraint on the lower 
thighs and a restraint that is anchored from behind the seatback will pull the subject down and 
back into the seat, thereby reducing variability in the seated-height measurement. Therefore, the 
recommendation given to the hardware designers after Flight 2 was to include a leg strap and an 
additional lap strap into the next restraint system prototype to be investigated during Flight 3. 
However, the seated-height data from Flight 2 proved that the variability between the Flight 2’s 3-
point harness, the 3-point harness with a leg strap, and the 3-point harness with the leg and lap 
straps was minor. Therefore, due to time and schedule constraints, the decision was made by the 
principal investigative team not to develop any additional hardware. 
 
With the restraint system decided on, Flight 3 examined the design of the prototype 
anthropometer and operationally verified the restraint method for crew procedures. Installing and 
operating the prototype anthropometer was also verified during Flight 3 for crew procedures; the 
installation and operation of the anthropometer was found to be straightforward. One lesson 
learned during Flight 3 was that the lap straps of the restraint must be tight against the subjects’ 
pelvis/waist to reduce the amount of variability in the seated-height measurements. 
 
The 3 microgravity flights allowed the principal investigation team to explore the best 
methodology for collecting seated-height data. The seated-height data collected during the 
microgravity flights assisted with crew procedures, data collection methodology, and hardware 
design. The lessons learned from the microgravity flights will aid in successfully and accurately 
collecting seated-height data that can be used by the CEV designers to accurately design for the 
amount of spinal lengthening due to microgravity. The spinal lengthening that crewmembers 
experience may affect crew safety, crew selection, and design requirements. If the designers do 
not have the correct data for spinal lengthening, a crewmember may not have enough clearance 
on reentry to allow for the appropriate vibration and stroke volume, or may not properly fit into 
the reentry suit, therefore affecting that crewmember’s safety and the safety of the other 
crewmembers. 
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PHOTOGRAPHS 
JSC2008E055472 to JSC2008E055494 
JSC2008E105506 to JSC2008E105524 
JSC2009E018274 to JSC2009E018302 
 
VIDEO 
• Zero-G flight week 7/22–25/08, Master nos. : 306440, 306441 
• Zero-G flight week 8/27–29/08, Master no.: 307073 
• Zero-G flight week 1/13–16/09, Master no.: 734616 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
 
CONTACT INFORMATION 
Sudahahkar Rajulu, Ph.D. 
NASA Lyndon B. Johnson Space Center 
Mail Code: SF3 
Houston, TX 77058 
281-483-3725 
 
 
 31 
TITLE 
C-9 Space Medicine Familiarization Flight 
 
FLIGHT DATE 
July 25, 2008 
 
PRINCIPAL INVESTIGATORS 
Heather Van Velson, Wyle Integrated Science and Engineering Group 
Bob Tweedy, Barrios 
 
CO-INVESTIGATORS 
David Ham, Wyle Integrated Science and Engineering Group 
Faith Knudsen, Wyle Integrated Science and Engineering Group 
Michelle Urbina, Wyle Integrated Science and Engineering Group 
Corinne Williams, Wyle Integrated Science and Engineering Group 
 
 
 
 
 32 
TEST OBJECTIVE 
Familiarize Medical Operations (Med Ops) personnel with the effects of microgravity on medical 
equipment and procedures, as well as the required process for conducting a C-9 flight. 
 
INTRODUCTION 
The space medicine familiarization flight provided Med Ops personnel with a better 
understanding of the effects of microgravity for use of medical procedures. Specifically, the time 
allotted on this flight was used to study intravenous (IV) fluid insertion, intubation, and cardio-
pulmonary resuscitation (CPR) in microgravity. Personnel who understand the limitations of 
medicine in a microgravity environment can use this knowledge to assist astronauts in a medical 
contingency or on-board training, design space-friendly medical equipment, and write procedures 
to better explain how to overcome the difficulties of operating medical equipment in microgravity. 
 
METHODS AND MATERIALS 
Preflight, all flyers were required to attend a C-9 Familiarization Training Session. At this 
training session, flyers were briefed on the bodily effects of the C-9, as well as given the oppor-
tunity to practice all procedures to be performed while flying on the C-9. Materials and 
procedures are explained thoroughly below. 
 
INSTRUMENTS 
The procedures and materials were divided into 3 stations: (1) intubation, (2) IV fluid insertion, 
and (3) CPR administration. 
 
Intubation Station 
The intubation station was composed of a plastic-human-upper body and the on-board airway 
subpack and intubation kit-airway (IKA) pack. Two methods of intubation were practiced: (1) 
intubating laryngeal mask airway (ILMA) device with an endotracheal tube and (2) laryngoscope 
with an endotracheal tube. 
 
IV Fluid Insertion Station 
The IV station consisted of a plastic-human arm, with fluid-filled tubes that substitute as veins, 
and the IV administration subpack on board the International Space Station (ISS).  
 
CPR Station 
The CPR station consisted of a life-sized, plastic dummy named Rescue Randy, attached via 
straps to the Crew Medical Restraint System (CMRS). CPR was practiced in 3 positions: (1) 
beside the patient, (2) straddled on patient, and (3) inverted position. 
 
PROCEDURES 
All personnel were trained on the following procedures prior to flight. Procedures used are 
detailed in the following attachments: 
 
Attachment 1 – ILMA Insertion 
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Attachment 2 – Intubation with Laryngoscope 
Attachment 3 – IV Insertion 
 
RESULTS 
Intubation Station  
Due to the number of co-investigators as well as the limited time (30 seconds) of microgravity 
per parabola, only the ILMA insertion procedure was able to be followed. The dummy was intu-
bated successfully on the first try, with lungs inflating properly on ventilation with the Ambu bag. 
 
During intubation, the ease of losing small objects that “float away” was definitely noticed. 
While everything is conveniently strapped down into the pack, recently used objects can float 
away during the procedure if not specifically placed in a secure position. In addition, on board the 
ISS, the patient would be strapped to the CMRS; this would require the Crew Medical Officer 
(CMO) to be strapped onto the CMRS by the patient’s head. This aspect of the procedure was not 
able to be practiced. 
 
 
IV Fluid Insertion Station 
The insertion of an intravenous catheter was achieved using the given procedure. The most 
difficult part of this procedure was securing the body of the IV administrator. However, placing 
legs underneath the metal table proved to be an efficient method for securing the co-
investigator’s body. Unfortunately, this table is not present on board the ISS. 
 
The propensity for small objects to float away was also noticed during IV insertion. The 
management of sharp objects was taken seriously, but could be a concern in a true microgravity 
environment, given the ease for losing such objects.  
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CPR Station 
All 3 stances of CPR administration were attempted. The inverted CPR was the fastest and most 
convenient method of CPR, as the other 2 options require coordination of straps for the CMO. 
Given the nature of a cardio-pulmonary emergency, the co-investigator would recommend 
attempting inverted CPR first for expediency. 
 
DISCUSSION 
The C-9 Space Medicine Familiarization Flight proved very useful, and test objectives were met. 
Med Ops personnel will now better relate to the challenges related to microgravity, as well as be 
equipped to improve the future of space medicine. 
 
The lack of body control was one of the most difficult aspects of microgravity. With medicine, 
the needs for gross and fine motor control are extremely important. Certainly, extended time in 
microgravity would allow one to adapt to such an environment. However, the acquisition of fine 
motor control in microgravity may never be as simple as in a gravitational environment. 
 
Losing small objects was another difficult aspect of working in microgravity. Even one small 
miscalculation in how well an object is strapped down can lead to losing that object. 
 
Both of these realizations will help the co-investigator in dealing with real-time calldowns from 
the crew on board the ISS. Medical operations personnel can better suggest methods of practicing 
medicine in microgravity in the event that a crewmember asks. The situational awareness also 
extends beyond medicine into all procedures that the crew performs. The time spent on the C-9 
was invaluable in acquainting the co-investigator with the challenges of microgravity. 
 
CONCLUSION 
The objectives of the C-9 Space Medicine Familiarization Flight were met. All co-investigators 
appreciated the exposure to microgravity and will use the lessons learned to benefit the future of 
space medicine. 
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Attachment 1 – ILMA Insertion 
  
 
Attachment 2 – Intubation with Laryngoscope 
1. Remove endotracheal (ET) tube from package. 
 Leave metal stylet inside ET tube. 
2. Lubricate cuffed end with Xylocaine® jelly. 
3. Fill syringe with 10 cc air. 
4. Insert syringe into one-way valve/pilot balloon on ET tube, inflate balloon, check integrity. 
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5. Deflate balloon, leave syringe connected with balloon deflated. 
6. Extend laryngoscope blade to 90-deg position. 
√ Light is on. 
7. Open mouth with fingers of right hand, with laryngoscope in left hand. Insert laryngoscope 
blade into right side of mouth, displacing tongue to left. 
WARNING 
Avoid pressure on lips, teeth. 
8. Advance laryngoscope blade into space between base of tongue, epiglottis. 
9. Lift tongue forward with laryngoscope blade tip to expose vocal cords. 
10. Advance cuffed end of ET tube along right side of mouth into trachea until entire cuff is 
about 1 cm below vocal cords. 
11. Holding ET tube in place, remove laryngoscope. 
WARNING 
Firmly hold ET tube in place until proper 
placement is confirmed and tube is taped. 
12. Inflate ET tube cuff with syringe until it feels tight (6–10cc), remove stylet. 
13. With mask removed, connect Ambu bag to ET tube to resume ventilation as soon as possible. 
 Squeeze bag until chest rises. 
 Allow passive exhalation. 
 Repeat every 5 seconds. 
14. Verify ET tube placement. 
 View patient’s lungs: 
 If evenly rising then good placement; continue to step 15. 
 If only one lung rising or one lung rises more than the other, tube is inserted too far 
into one lung; deflate and move out 1 to2 cm. 
 Check for evenly rising lungs. 
 If yes, continue to step 15. 
 If no, remove tube and go back to step 6. 
 If stomach inflates, deflate and remove tube and go to step 6. 
15. Ventilate for 30 seconds, then remove Ambu bag. 
 
Attachment 3 – IV Insertion 
1. Tear off 4 pieces of tape approximately 4 in. long. 
2. Remove cap (not rubber port) from saline bag. Remove protective cap from spike of IV 
administration set. 
3. Make sure IV administration set roller clamp is closed. 
4. Insert saline bag into IV pressure infusor and inflate. 
5. Tie tourniquet tightly around upper arm and locate vein. 
6. Don non-sterile gloves (optional). 
7. Pretend to do this step: Clean a wide area over vein with an iodine pad by starting in the 
center and moving outward in expanding circles; fan to dry. 
8. Remove 16G catheter from package. Twist the Teflon® piece (around the needle) to loosen. 
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9. Capture vein between thumb and index finger of nondominant hand. 
10. With needle bevel up, puncture skin over vein. 
11. Slightly drop angle of needle and insert 1 to 2 mm more to ensure Teflon® catheter is 
properly placed in vein. 
12. While holding needle stationary, advance Teflon® catheter into vein. 
13. While holding Teflon® catheter with needle in place, remove tourniquet. 
14. Apply pressure on vein (above end of catheter tip) with finger; remove needle and quickly 
attach Y-type catheter (on IV administration set) to the Teflon® catheter. 
 
15. Dispose of needle in sharps container. 
16. Secure IV tubing like a “chevron” on the arm with tape. 
17. Assemble Tubex injector and “administer drugs” into Y-type catheter. 
 
PHOTOGRAPHS 
JSC2008E055775 through JSC2008E055805 
 
VIDEO 
• Zero-G flight week 7/22–7/25/08, Master nos.: 306440, 306441 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
 
CONTACT INFORMATION 
Robert Tweedy 
Wyle Integrated Science and Engineering Group 
1290 Hercules Suite 120 
Houston, TX 77058 
Robert.Tweedy-1@nasa.gov 
 
DO NOT open roller-clamp 
No fluid is allowed to be transferred 
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GOALS/OBJECTIVES 
The goals of the zero-G experiments included specific tests to verify the FASTRACK 
engineering unit prior to fabrication of the flight units. Three investigations were conducted in 
conjunction with FASTRACK. The first FASTRACK middeck locker housed the Space 
Acceleration Measurement System (SAMS) hardware. This hardware has previously flown on 
numerous space shuttle missions and is currently being used on the ISS. The SAMS hardware 
was used to collect acceleration data in various locations on the FASTRACK hardware. The 
second FASTRACK middeck locker housed an experiment looking at the phenomenon of 
Faraday-wave interface in 2 non-mixable fluid interfaces. The third experiment included 1 
component (a receiver) that flew in the SAMS locker and received transmissions from the NcIQ 
noncontact sensor unit that was worn by one of the FASTRACK flyers. 
 
Major goals of the study 
• To demonstrate the FASTRACK engineering unit interfaces and operational procedures for 
use on parabolic flights 
• To validate the performance of rack systems and power support in the microgravity 
environment prior to the fabrication of flight units 
• To collect baseline characterization data of the microgravity environment in the FASTRACK 
payload accommodations using SAMS instrumentation and test experiments that have 
previously flown 
• To conduct a fluid dynamics experiment to study the Faraday-wave interface in 2 non-
mixable fluid interfaces 
• To conduct a test of the NcIQ hardware to provide hemodynamic status monitoring in a 
variable gravity environment 
 
METHODS AND MATERIALS 
FASTRACK 
The 2 single-middeck-locker FASTRACK configuration was used for the zero-G flights (figure 
1). The overall FASTRACK dimensions are 24 in×24 in×36 in, and the overall weight is 300 lbs. 
The FASTRACK rack structure is made from 80/20 extrusion hardware, which is lightweight, 
has superb material quality (6105-T5 aluminum and carbon steel), has a drop-lock feature that 
makes it vibration-proof, and has proven structural integrity as well as fastener application 
quality. The middeck lockers are mounted to the FASTRACK frame via back plates. The back 
plate bolt patterns and fasteners are the same as those used to mount the lockers to the space 
shuttle or to the ISS EXPRESS Racks. In addition to the 2 middeck lockers, a support drawer 
located at the bottom of the FASTRACK structure contained all supporting electrical equipment 
as well as a front panel to serve as a user interface for FASTRACK and its experiments. The 
FASTRACK was mounted to the aircraft using ZERO-G®-provided bolts. 
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Figure 1. FASTRACK mounted to ZERO-G® aircraft floor. 
 
SAMS 
The SAMS hardware has previously flown on numerous space shuttle missions and is currently 
in use on the ISS. The triaxial-sensor-head, Ethernet-standalone (TSH-ES) component was flown 
during the FASTRACK zero-G campaign (figure 2). 
 
 
Figure 2. Triaxial sensor head-Ethernet standalone. 
 
The TSH-ES consists of 3 analog accelerometers and 3 temperature sensors. It senses 
acceleration and provides a digital signal to the control unit via Ethernet. The TSH-ES has in-
ternal processing capabilities, which allow it to interface directly with the SAMS laptop. The 
SAMS laptop was located in the first FASTRACK middeck locker. The TSH-ES is attached 
using 4 integral spring-loaded captive screw assemblies with nut retainers. It was attached to a 
different location on FASTRACK for each flight day. All 4 fasteners were used to secure the 
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TSH-ES to provide a fail-safe condition as well as to ensure a rigid connection between the TSH-
SE and the FASTRACK. A TSH-SE cable, which connected the TSH-SE to the SAMS laptop, 
contained all power and data connections. 
 
Faraday-Wave Interface Experiment 
The Faraday-wave-interface experiment was located in the second FASTRACK middeck locker 
(figure 3). Each experiment run used a petri dish filled with 30 mL of liquid. The petri dish was 
glued shut. One petri dish contained water, the second petri dish contained a mixture of water 
and oil, and the third and fourth petri dishes contained a mixture of water and corn starch. A 
single petri dish flew each day; petri dishes were replaced on subsequent flight days. All Faraday-
wave equipment was mounted to a wood box. The front of the box had a hinged panel to enable 
the operator to switch out memory cards on the video camera during the flights. With the excep-
tion of the video camera, all powered equipment associated with the Faraday-wave experiment 
ran on three 9-volt batteries. A function generator (small, portable), an amplifier (from a 
computer speaker box), and a 4-in speaker were beneath the petri dish to generate the ripples on 
the liquid interfaces. The video camera was mounted next to the petri dish to record data; a small 
lamp was used to illuminate the area. The Faraday-wave-interface experiment did not interface 
with the FASTRACK support drawer or the lithium polymer (LIPO)-32 battery pack. Prior to the 
start of parabolas, the user opened the middeck locker door and turn on the power switch to the 
Faraday-wave equipment and the video camera. The middeck locker door was closed during the 
parabolas. The middeck locker door was opened again on completion of the parabolas to power 
down the experiment and video camera. There were no other in-flight operations associated with 
this experiment. 
 
 
Figure 3. An operator performs a status check of the Faraday-waves  
experiment during the parabolic flights. 
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N
c
IQ™ Experiment 
The NcIQ experiment used commercially available, off-the-shelf hardware provided by 
Noninvasive Medical Technologies Inc. (NMT) (figure 4). The NcIQ uses patented technology to 
measure the reflected electrical signal length from anatomical structures in motion. The signal 
generated by the NcIQ is integrated into the NMT IQ algorithm, and the following hemodynamic 
parameters are measured: cardiac output, heart rate, respirations, and life score. The NcIQ 
noncontact sensor is 3 in×1 in×4 in and weighs less than 6 oz. The NcIQ noncontact sensor, 
which does not require skin contact for proper operation, was worn in the pocket of the operator 
during the parabolic flights. 
 
 
Figure 4. N
c
IQ Noncontact Sensor. 
 
The NcIQ noncontact sensor operates on an internal 4.7-volt non-rechargeable battery 
manufactured by Inspired Energy (Model NC2040HD). The NcIQ noncontact sensor transmits 
data to a data manager receiver that was located inside the locker containing the SAMS laptop 
(figure 5). The data manager receiver was attached to the inside of the middeck locker using 
Velcro. The NcIQ noncontact sensor produces a fixed, single-frequency, sinusoidal signal in the 
902 MHz to 928 MHz ISM [industrial, scientific, and medial] frequency band, which is typically 
centered at 915 MHz (similar to a cellular phone). The signal was applied for 30 seconds for a 2-
minute measurement process for a 25% duty cycle, which follows the standards and exposure 
restrictions set by the Institute of Electrical and Electronic Engineers (IEEE) Std. C95.1™-2005. 
The calculated specific absorption rate (SARpeak=5.8419 mW/Kg, SARnominal=1.4605 mW/Kg for 
10 grams of tissue) maximum for the NcIQ noncontact sensor is <4% of the limit (Basic 
Restriction SAR=160 mW/Kg for 10 grams of tissue). The data manager receiver operates on AA 
alkaline batteries and can receive a signal from the noncontact sensor as far away as 500 ft, with 
or without a line of sight. 
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Figure 5. N
c
IQ data manager receiver. 
 
RESULTS 
1. FASTRACK: The engineering unit interfaces and operational procedures were successfully 
demonstrated. The FASTRACK rack system and power support were successfully validated 
in the microgravity environment. This enabled the FASTRACK team to evaluate the 
FASTRACK design prior to fabricating the flight units. 
2. SAMS: The SAMS accelerometer data were collected without issue and provided valuable 
insight into the forces applied to different locations on the FASTRACK hardware during 
parabolic flight. 
3. Faraday Waves: The Faraday-waves experiment had several technical glitches that prevented 
experiment success. The adhesive holding the petri dish cover to the petri dish base was not 
always adequate to contain moisture. A small amount of liquid was released from the petri 
plate on the first flight day, and the experiment had to be shut down to prevent damage to the 
Faraday-waves hardware. The video camera was unable to film the Faraday waves in the petri 
dish due to the liquid obscuring the view through the petri dish cover during parabolas. While 
the results of this experiment were disappointing, the Faraday-waves investigators’ team had 
several lessons learned that they will incorporate if the experiment is to be repeated in the 
future. 
4. NcIQ: The NcIQ hardware performed very well overall. The NcIQ user wore the noncontact 
sensor inside his/her flight suit pocket. This worked well for most of the parabolas, although 
data dropouts between the noncontact sensor and the receiver did occur. The NcIQ equipment 
has been tested in a variety of extreme conditions. The additional testing in microgravity has 
helped to further define the ruggedness and accuracy of this hardware in extreme conditions. 
 
CONCLUSION 
As per previous experience, parabolic flights have proven invaluable in testing hardware 
designs and performance in microgravity. The validation of the FASTRACK design gives the 
engineering team the confidence that the current design will meet the future microgravity re-
quirements for this hardware. The validation that the NcIQ can provide reliable and accurate 
data while in the subjects’ pocket in microgravity conditions gives the manufacturer further 
data to show that its hardware is reliable in a wide variety of environments. 
 
 44 
PHOTOGRAPHS 
JSC2008E116066 to JSC2008E116067 
JSC2008E116081 to JSC2008E116078 
JSC2008E118171 to JSC2008E118177 
 
VIDEO  
• Zero-G flight week 9/9–9/10/08, Master no.: DV1721 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
 
CONTACT INFORMATION 
For more information on the FASTRACK or SAMS hardware, contact: 
Robert Soler 
The Bionetics Corporation 
Kennedy Space Center, FL 
(321) 861-3047 
Robert.R.Soler@nasa.gov 
 
For more information on the Faraday Waves experiment, contact: 
Larry Chew, Ph.D. 
University of Central Florida 
Phone: (407) 924-3179 
Email: teducators@hotmail.com 
For more information on the N
c
IQ hardware, contact: 
Luis Moreno, M.D. 
The Bionetics Corporation 
Kennedy Space Center, FL 
Phone: (321) 867-3827 
Email: Luis.A.Moreno@nasa.gov 
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GOALS 
• Refine the human factors for eye exams using ultrasound and applanation tonography while 
observing ophthalmic morphometrics in response to microgravity and hypergravity. 
• Map human ophthalmic nerve changes in response to physiologic maneuvers. 
• Determine human choroid thickness changes in response to microgravity 
• Measure intraocular pressure changes in response to microgravity. 
 
INTRODUCTION 
In past parabolic flights provided by the Reduced Gravity Office (RGO), Med Ops has performed 
a variety of ultrasound research objectives. Med Ops and the Advanced Diagnostic Ultrasound in 
Microgravity (ADUM) research team engaged in a broad range of experiments and testing in 
clinical and research uses of ultrasound with the RGO and on the ISS (Chiao et al., 2005; 
Hamilton et al., 2004). As related to human testing of ophthalmic ultrasound in parabolic flights, 
the ADUM team has had some limited exposure on the previously flown C-9 aircraft. 
Additionally, Med Ops experimented with visualization and mapping of the ophthalmic nerve 
sheath to investigate the correlation between nerve diameter and intracranial pressures (ICPs). 
This project was based on seminal work by Dr. Blavias et al., which demonstrated that ICP 
correlates with optic nerve diameters as seen by ultrasound (Newman et al., 2002). In this 
experiment, the Med Ops team directly measured ICP and changed the ICP in the animal (pig) 
while the nerve diameter was monitored with high-frequency ultrasound at micro- and 
hypergravity on board the C-9. 
 
Zero Gravity Corporation (ZERO-G) presented Med Ops with an opportunity to fly scientific 
research in their aircraft provided that the potential experiment required limited labor and re-
sources. The Med Ops team designed an experiment that offered valuable data and used minimal 
resources. Despite a compendium of prior work, including the ADUM experiments, data are still 
very limited on the human factors of eye ultrasound exams in a microgravity environment. The 
team designed an experiment looking at changes in the human eye during microgravity. 
 
The protocol and corresponding documentation was drafted, presented, and approved by the 
NASA JSC Committee for the Protection of Human Subjects (CPHS). After approval, events on 
the ISS sparked an interest and led to a last-moment change to the protocol. 
 
The principal investigator (PI), Dr. D. Hamilton, was informed by one of his collaborators, Dr. C. 
Gibson, NASA JSC Optometrist, regarding ophthalmic changes occurring in astronauts that 
appeared to be specific to microgravity exposure. These physiologic changes involved decrease 
in near visual acuity, choroid (inner vascular layer of tissue behind the retina), and nerve edema. 
Direct intraocular pressure (IOP) measurements on the eye were taken using the applanation 
tonography protocol currently being flown on the ISS. In previous parabolic flight experiments, 
IOP measurements had been successfully performed by Dr. Gibson and Dr. Tom Mader during 
parabolic flight aboard KC-135 aircraft (DSO [Detailed Science Objective] 472). With these 
events in mind, the PI, Dr. Gibson, and the Med Ops team rationalized that perhaps ultrasound 
also could be used to assess choroid changes as it is available in the Human Research Facility 
(HRF) aboard the ISS. But, could the choroid changes actually be seen with ultrasound in mi-
crogravity? IOP, nerve, and choroid thickness change correlation has never been compared in 
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humans in a microgravity environment. Since both IOP and ultrasound testing modalities are 
available in the ISS, the experiment was refined to include IOP measurements for correlation 
with ultrasound measurements. The addition of a tonometry measurement protocol was approved 
by the NASA JSC CPHS by expedited review. 
 
METHODS AND MATERIALS 
Ultrasound was digitally captured in still frames and audio visual interface (AVI) loops using a 
portable ultrasound device with an 18-MHz, broad-band-linear probe manufactured by Biosound 
Esaote Inc. Video output from the ultrasound machine was recorded to a digital video recording 
device to serve as (1) a back-up data saving plan, and (2) a record of the entire data collection 
process. Ultrasound gel manufactured by Aquasonic Inc. was applied to the closed eyelid of the 
volunteer subject. IOP measurements were taken using a TONO-PEN AVIA made by Reichert 
International. Prior to applanation for IOP data collection, volunteer subjects were treated with a 
single drop of proparacaine 0.5% (anesthetic eye drops). 
 
During mapping of the optic nerve diameter and Doppler measurement of blood flow into the 
eye, the volunteer subjects performed controlled Valsalva and Muller maneuvers by blowing and 
sucking, respectively, into a pressure measurement device (PMD). The PMD is a negative and 
positive pressure-breathing device designed to monitor and store the pressure effort from 
breathing into the mouthpiece, built by Wyle Integrated Science and Engineering Group. 
 
The experiment was videotaped with both mounted and handheld video cameras. This 
experiment consisted of 60 parabolas, all of which were microgravity. 
 
The team for the experiment consisted of 1 TONO-PEN/PMD operator, an ultrasound operator, 
and a volunteer subject. There were 3 volunteer subjects who participated for 20 parabolas each. 
Each subject was also participating in a separate experiment on the plane and, therefore, was not 
exclusively dedicated to the eye experiment. This reduced the amount of resources needed for 
completion of the experiment. All subjects had identical testing on the ground the week prior to 
flight testing. During a 20-parabola set in flight, ultrasound was performed for the first 15 
parabolas and IOP using the TONO-PEN was performed for the last 5 parabolas on each of the 3 
volunteer subjects. 
 
Parabolas 1–15: Ultrasound 
Ultrasound monitoring with intermittent color-flow Doppler and pulse-wave Doppler continued 
on the eye throughout the microgravity phase of the parabola and into the hypergravity phase. 
The volunteer subject was coached to stare a forward gaze with the contra lateral eye. Due to the 
very short phases of microgravity and dynamics of the eye, quality images would be impossible 
to reacquire by removing the probe during hypergravity phase and reapplying it again at the top 
of the parabola. The safety and comfort of each volunteer subject was monitored by both oper-
ators and a dedicated flight crewmember who was (1) seated in the experimentation area and (2) 
in communication with the flight crew, as needed. The TONO-PEN operator acted as the PMD 
operator during the physiologic maneuvers of Valsalva and Muller. While the optic nerve was 
being scanned, the subject blew into the mouthpiece of the PMD and was coached to maintain a 
 48 
consistent 30 mmHg for Valsalva or negative 30 mmHg for Muller for the duration of the 
parabola. 
 
 
Ultrasound operator scanning the optic nerve over the eyelid  
with a high-frequency linear probe. 
 
During parabolas when the TONO-PEN/PMD operator was not engaged with human testing, 
applanation was done on an eye simulator Eyetech Ltd. This is the identical device that was used 
to train the ISS crew in applanation tonography and is a pressure modulator with 3 controlled 
settings. This simulator acted as a control for the IOP experiment. 
 
Parabolas 16–20: IOP Measurements 
After parabola 15, the subject wiped his/her eye free of ultrasound gel, and the ultrasound 
operator placed 1 numbing drop into the right eye just as the parabola was going into the 
hypergravity phase. The TONO-PEN/PMD operator performed applanation tonometry at the top 
of the microgravity portion of parabolas 16 through 20. The IOP was successfully measured 1 to 
2 times per parabola, depending on the length of each parabola. Parabolas ranged in length from 
10 seconds to 17 seconds. 
 
 
TONO-PEN/PMD operator performing applanation on the cornea of the anesthetized eye  
measure intraocular pressure. 
 
RESULTS/DISCUSSION/CONCLUSION 
The results of this investigation are not finalized, and additional analysis of the ultrasound 
images has yet to be complete. However, the IOP measurements are complete and show minimal 
pressure increases in parabolic flight. Ophthalmologist Dr. T. Mader (currently practicing in 
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Anchorage, AK) had flown an earlier version of the TONO-PEN in an experiment for NASA on 
KC-135 aircraft (DSO 0472). He communicated that this minimal change is largely due to the 
reduced time in zero gravity. Previous flight experiments on the KC-135 have also shown that 
there was a more significant increase in ocular pressure because the exposure to microgravity 
was longer. NASA JSC Optometrist Dr. C. Gibson agrees, and has added that the fluid shift was 
not as prolonged for this investigation; therefore, the pressure in the eye did not have enough time 
to elevate as in previous experiences on the KC-135. The parabolas for this flight were excep-
tionally short intervals, which reduced exposure to microgravity and, thus, also reduced the 
physiologic effects normally observed on volunteer subjects. 
 
The choroid, which was the original area of interest, was identified with ultrasound. This is an 
initial effort in determining whether the choroid could be visualized in microgravity and by no 
means should be considered a final product but, rather, an influential forward progress. Additional 
data are needed to show conclusively that this vascular bed changes with acute changes in gravity. 
The significance of changes in the choroid structure may be statistically relevant with a larger 
subject population. Our study consisted of 3 subjects total, and the final results are pending 
completion. The initial data are interesting and reproducible with the single experienced operator 
for both the ultrasound and tonometry. The dynamics and human factors involved have not been 
completely refined due, in part, to the fact that the volunteer subjects had a difficult time holding 
a forward gaze during the flight. Without mechanically “fixing” the gaze, it seems likely that this 
may be a factor that cannot be changed, and additional data takes could be helpful in deciding 
whether alternative gazes yield similar results. The images with “off-axis gaze” were readily 
attainable and could potentially capture the region, which is the area of the back of the eye that 
we were trying to acquire. We are currently collaborating with Dr. Tom Mader, Ophthalmologist 
from Anchorage, AK (previously mentioned), and eye ultrasound expert, Professor Dr. Anastas 
Pass from the University of Houston in our interpretation of the data. 
 
REFERENCES 
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Ocular examination for trauma; clinical ultrasound aboard the International Space Station. J 
Trauma; 2005. 
2. Hamilton DR, Sargsyan AE, et al. Sonographic detection of pneumothorax and hemothorax 
in microgravity. Aviat Space Environ Med; 2004. 
3. Newman WD, Hollman AS, et al. Measurement of optic nerve sheath by ultrasound: a means 
of detecting acute raised intracranial pressure in hydrocephalus. Br J Ophthalmol; 2002. 
4. Referenced communication from Dr. Gibson NASA ophthalmologist: Vision Changes and 
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PHOTOGRAPHS 
JSC2008E147963 to JSC2008E147965 
JSC2008E147967 
JSC2008E147978 to JSC2008E147983 
JSC2008E147994 to JSC2008E147996 
JSC2008E148005 to JSC2008E148006 
 
VIDEO 
• Zero-G flight week 11/18–11/21/08, Master nos.: 881350, 881289, 881290 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
 
CONTACT INFORMATION 
Kathleen Garcia 
Advanced Projects Group 
Wyle Integrated Science and Engineering Group 
1290 Hercules Avenue 
Suite 120 (MC: W1C) 
Houston, TX 77058 
(281) 212-1364 
kgarcia@wylehou.com 
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GOAL 
To validate the principle of a portable blood count instrument prototype in microgravity 
environment and to determine whether the performance is comparable to that of ground-based 
testing. 
 
INTRODUCTION 
The purpose of this study is to perform a protocol evaluation of the portable blood count 
instrument (BCI) to determine whether the principle of the BCI works under the microgravity 
environment, and whether the performance of the instrument is the same as that seen in ground-
based testing. The California Institute of Technology Micromachining Laboratory (CITML) co-
operated with the Advanced Projects (AP) group of Wyle Integrated Science and Engineering 
Group (Houston) to conduct this evaluation. 
 
Blood count is an important medical test that is known to supply a rapid assessment of diseases 
such as anemia, infection, inflammation, acute radiation syndrome, and immunosuppression. The 
test provides a useful health-monitoring method for astronauts, especially when they experience 
stress or are exposed to radiation during space missions. However, the commercially available 
blood counters are usually heavy and bulky and occupy a volume greater than 105 cm3. This is a 
concern considering that space missions require small-sized medical instruments due to limited 
on-board space. 
 
To address this concern, CITML has been tasked to develop and demonstrate an automated 
portable BCI that is easy for astronauts to operate in space (Zheng et al., 2008). A prototype BCI 
has been recently designed and tested in a terrestrial environment (figure1). Fluorescence-based 
microflow cytometry is employed to count the number of cells in the blood sample, and a micro-
fluidic device is used as a disposable cartridge for detection. A blue-light-emitting diode (LED) 
is used as the excitation source (figure 2). The excitation light is filtered and condensed onto the 
detection zone of the micro-device. The blood sample is drawn through the micro-device by a 
mini-peristaltic pump. The fluorescence signal from the stained blood cells is collected, split into 
2 colors, and measured by 2 photon-multiplication tubes (PMTs). Blood count, including both 
leukocyte absolute count and a lymphocyte ratio, can be conducted with this portable BCI 
prototype. 
 
  
Figure 1. The prototype BCI. Figure 2. The optical configuration of the BCI. 
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To assess the feasibility of using the BCI under microgravity environment, the CITML and the 
AP group conducted and evaluated blood counts with blood samples from healthy donors using 
the BCI prototype devices during parabolic flight aboard the ZERO-G® Corporation aircraft. 
 
OBJECTIVE 
To validate the principle of a portable BCI prototype in the microgravity environment and 
determine whether the performance is comparable to that of ground-based testing. 
 
METHODS AND MATERIALS 
Two BCI prototype devices were used in the flight test. One BCI was used to test a blood sample 
while the other BCI performed a control test using fluorescent beads. For the blood sample, a 
volume of 100 μL of human blood from a healthy donor was stained with 100 μL Acridine 
Orange solution (concentration 200 μg/mL) for 5 minutes under room temperature, and then 
diluted to a total volume of 1,500 μL with Ficoll-Paque. For the control sample, green 
fluorescence beads (5-μm diameter) were diluted with Ficoll-Paque to a concentration of 105 
beads/μL and a total volume of 1,500 μL. Samples were prepared and loaded onto the BCI 
prototypes during the on-ground preparation just before take off of the aircraft. 
 
The tests were started by turning on the BCI prototypes after the aircraft took off. The data of the 
detected signals were recorded on 2 laptop computers connected to the BCI prototype with 
universal serial bus (USB) cables (figure 3). The starting time of the test was recorded by a flight 
crewmember from AP (figure 4) to ensure that the test time could be synchronized with the 
acceleration data during the 60-parabola-flight time. The acceleration data were recorded by a 
separate accelerometer on the rack on the flight. All of the data were saved and analyzed 
afterwards. 
 
  
Figure 3. The BCI prototype and the laptop computer  Figure 4. Flight crew turned on the BCI and  
for data recording. recorded the test starting time. 
 
RESULTS/DISCUSSION/CONCLUSION 
Preliminary analysis of the data shows that the portable BCI prototype worked under the 
reduced-gravity environment. The fluorescence signal of the blood cell count showed no 
observable difference from the results of ground tests. The low-environment pressure (~6 pounds 
per square inch [psi] versus 14 psi atmosphere pressure) during the flight test reduced the pumping 
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efficiency of the peristaltic pump used in the BSI prototype. The power of the pump should be 
increased for future flight tests. The data will be formally analyzed and written up by the CITML 
for peer review. 
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preparation and execution for this evaluation: Advanced Projects at Wyle Integrated Science and 
Engineering Group, and the NASA JSC RGO. 
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PHOTOGRAPHS 
JSC2008E147966 
JSC2008E148007 to JSC2008E148008 
 
VIDEO 
• Zero-G flight week 11/18–11/21/08, Master nos.: 881350, 881289, 881290 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
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(626) 395-8317 
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GOALS 
• Identify appropriate size vial required to withdraw a defined drug volume. 
• Identify hardware that facilitates withdrawal of the appropriate volume of drug from vial 
(blunt cannula with syringe, needleless valve, syringe size, etc.). 
• Identify fluid properties of ISS-related medications that would prevent withdrawal of 
medication from vial using identified hardware (viscosity, foaming, particulate formation, 
etc.). 
• Video record procedure used to withdraw medication from a vial into a syringe for use with 
on-orbit procedure. 
 
INTRODUCTION 
The current system for injectable medications aboard the ISS has experienced a materials failure 
that requires a new system for injectable medications to be identified and flown. It is desired that 
this new system will fly medications for injection in their original manufacturer packaging. This 
will allow the system to comply with United States Pharmacopeia (USP) guidelines while mini-
mizing the frequency of resupply due to medication expiration. However, this change will require 
crew to draw liquid medications for injection from a glass vial into a syringe prior to injection. 
 
This experiment will evaluate the effectiveness of various needleless-vial adaptors to facilitate 
the withdrawal of liquid medication from a glass medication vial into a syringe for injection within 
a microgravity environment. Other parameters to be assessed include determining the ability to 
withdraw the required amount of medication, and whether this is dependent on vial size, liquid 
viscosity, or the total volume of fluid within the vial. Liquid medications proposed for flight on 
the ISS will be used for this experiment. 
 
DISCLAIMER 
The content of this report should not be considered final and binding. Formal review and 
evaluation of all data collected will be the subject of final reports and publications when deemed 
appropriate. The content of this report should permit the reader to become familiar with the pro-
cedures followed and the preliminary observations and lessons learned. This document neither 
endorses nor rejects the performance of any commercial products used. 
 
Medications for injection are commercially available in a variety of forms including glass/plastic 
single-dose vials, glass/plastic multi-dose vials, and prefilled syringes. Whenever possible, it is 
desired that injectable medications for use on the ISS be delivered in a prefilled syringe to limit 
the need for astronauts to manipulate the medication prior to administration. However, the 
healthcare market is constantly evolving based on new evidence sources and changing standards 
of care, meaning that medications are not consistently available at the desired strengths or 
volumes in the same packaging over a period of time. 
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In the event medications must be supplied in a vial, a system is required that allows for the safe 
withdrawal of medication from the vial into a syringe for administration. Traditionally, this method 
of withdrawal requires the use of a needle. In an effort to limit risk of inadvertent needle sticks, 
the healthcare marketplace has a variety of needleless-vial adaptors that allow direct connection 
of a syringe to a medication vial, eliminating the need for a needle to pierce the vial septum. These 
vial adaptors, in some instances, can also offer the protection of a re-sealable, swabbable barrier, 
thus preventing inadvertent contamination of medications from repeated withdrawals over a 
period of time. For ease of training and in an attempt to minimize multiple variations of hard-
ware, it is desired that the hardware of choice be a single system that is effective for use no 
matter what vial size or syringe is selected. 
 
OBJECTIVE 
Identify issues related to the withdrawal of liquid medication for injection from a glass medi-
cation vial into a syringe within a microgravity environment using a needleless-vial adaptor. 
 
METHODS AND MATERIALS 
A market survey of needleless-vial adaptors was performed, and a representative sample was 
obtained for further evaluation. A small group consisting of a pharmacist, engineers, and nurses 
evaluated the narrowed field of hardware and identified 3 primary pieces of hardware for further 
testing. The original experiment design was based on 1-G ground-testing of 3 different vial 
adaptors followed by microgravity testing of the 2 best candidates. Due to a shipping delay, 1 of 
the 3 vial adaptors was unable to be obtained in time for ground/inflight testing. Please refer to 
the Future Studies section for further information on this hardware. 
 
It was also desired to evaluate the volume of air and its behavior in prefilled medication syringes 
packaged by the manufacturer. Four sample medications were obtained for observation during 
the flight. 
 
Figure 1. Carpuject® syringe (current 
method of injectable meds on the 
ISS). 
Figure 3. Commercially 
prepared pre-filled 
medication syringes. 
Figure 2. Single-dose and multi-dose 
medication vials (current method of 
injectable meds on the ISS). 
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Figure 4. Cap vial adaptor. Figure 5. Spike vial adaptor. Figure 6. Blunt cannula vial adaptor. 
 
1-G ground-testing was completed using medications in similar volume and concentration to 
those currently flown on the ISS. The experiment was designed to be evaluated within 60 
parabolas, lasting approximately 20 seconds each, with testing divided into 3 segments: Segment 
1 – Cap-vial adaptor testing; Segment 2 – Spike-vial adaptor testing; Segment 3 – Video 
documentation of the procedure steps required to withdraw medication from the vial into the 
syringe. Two participants were used to conduct the ground and flight testing, with the first 
participant assembling hardware and the second participant withdrawing the medications during 
the microgravity portion. Two fixed video cameras were used to document the experiment, and 2 
handheld cameras were used intermittently throughout the flight. Still images were also captured 
at various stages of the experiment. Feedback on each medication and device was captured by 
activated microphones attached to both participants. Materials were immobilized using Velcro® 
and foam blocks for safety during periods of aircraft turbulence and during microgravity portions 
of the flight. Sharp objects (i.e., plastic vial adaptors, medication vials) were disposed of in a 
sharps container attached to the table used in the experiment. Any liquids that were inadvertently 
released during microgravity portions of the flight were captured using towels secured to the 
work surface. A postflight debriefing was conducted by the 2 flight evaluators, and still 
photographs were taken of problematic hardware/vials. 
 
RESULTS/DISCUSSION/CONCLUSION 
The microgravity portion of testing highlighted 3 areas of focus when attempting to draw up a 
medication in microgravity in addition to revealing information on the vial adaptors tested. 
Specific areas for discussion are: (1) fluid isolation in medication vial, (2) withdrawal of medica-
tion into syringe and use of air injection into the vial for pressure equalization, and (3) air/fluid 
separation in a syringe. 
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Figure 7. Fluid isolation in medication vial (cap vial adaptor testing). 
 
Fluid isolation in the medication vial: In all instances, the medication vials were spiked with a 
syringe/vial adaptor assembly prior to fluid isolation in vial. Maneuvers were used to facilitate 
separation of air and fluid in the vial while moving fluid to the end of the vial that was closest to 
the septum. These fluid isolation maneuvers may be achieved in multiple ways, all of which, 
based on experience of fluid management in microgravity, may be performed according to the 
preference of the astronaut. If vial adaptors and syringes are attached to a vial before fluid is 
isolated in the vial, consideration of how that vial is manipulated should be based on the stability 
of the assembly attachment. Holding the vial in hand to prevent “slinging” of the vial off the 
adaptor is a recommended action. Alternatively, fluid isolation can be performed prior to 
attaching the syringe/vial adaptor assembly. Limitations of the ZERO-G® flight prevented 
analysis of microbubbles in solution created by launch forces, and it is anticipated that this will 
be more of an issue in a sustained microgravity environment compared to this test flight. 
 
 
Figure 8. Withdrawal of medical into syringe (spike vial adaptor testing). 
 
Withdrawal of medication into syringe: Terrestrial practices for medication withdrawal from a 
non-vented vial require injection of an equivalent amount of air as the expected medication 
volume prior to inverting the vial and withdrawing liquid. This practice eliminates the resistance 
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of the syringe plunger pulling against a higher vial pressure as the drug is withdrawn. In micro-
gravity, this rationale is still valid; however, the injection of additional air into the vial creates a 
multitude of microbubbles and increases the volume of medication mixed with air that must be 
withdrawn to achieve the desired drug volume in syringe. This practice is more likely to be re-
quired when using vials >30 mL in size and injection volumes >10 mL. It is felt that, based on 
the microgravity flight, the practice of air injection is more of a hindrance than help. 
 
Figure 9. Trapping of fluid in medication vial due to flight  
adhesion (spike vial adaptor testing). 
 
It was found that single-dose-medication vials present a problem in accessing the entire drug 
volume required for administration. At issue is the manufacturer’s air bubble in the vial. In 
microgravity, this air bubble traps fluid along the sides and base of the vial despite effective 
air/fluid separation prior to medication withdrawal. Manufacturers typically provide some over-
fill of the vial, but this volume is not predictable. Terrestrially, any fluid that is not immediately 
at the septum may be “chased” using a needle that can be manipulated to the liquid bubble. Both 
vial adaptors tested limited this ability to chase pockets of medication in the vial either due to the 
locking mechanisms on the vial top or the length of the spike. The spike-vial-adaptor length was 
also limiting in vials holding <3 mL of fluid. The spike length (in relation to where the fluid 
ports on the spike) was too long to allow access to all the fluid in the vial. Use of single-dose 
vials without the ability to “chase” fluid risks the possibility of the inability to access all the 
desired medication from the vial. 
 
 
Figure 10. Air/fluid separation in syringe. 
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Air/fluid separation in syringe: Due to dead space within vial adaptors, some air will inevitably be 
mixed into medications as they are withdrawn into a syringe, despite effective fluid isolation in 
vial. This air, combined with any microbubbles that are possibly still in solution, will require a 
second effort on the part of the astronaut to isolate fluid in the syringe prior to medication admin-
istration. Selection of a syringe size larger than the volume required is considered to be helpful so 
that a larger volume than necessary may be withdrawn followed by fluid and air being isolated 
and then extra air ejected from syringe. 
 
In the prefilled syringes packaged by the manufacturer, the air volume within the syringe varied. 
This was due to varying fluid volumes in each of the syringes as well as to different packaging. 
During 2 parabolas, it was noted that the air in each of the prefilled syringes separated to form 
smaller air bubbles. Fluid/air isolation techniques were evaluated. It was decided that the pres-
ence of air within these syringes would not pose a problem for medication administration in 
microgravity once the isolation technique was used. 
 
Hardware selection: While advantages can be observed for both pieces of hardware, it was felt 
that the cap vial adaptor was the superior choice of the 2 pieces of hardware. The cap serves as a 
physical barrier between the septum and the environment, which would be helpful, especially for 
multi-dose vials that might be restowed within the ISS medical kits. Its smaller diameter spike is 
also markedly superior in perforating the rubber septum without causing displacement that causes 
leakage. The spike is short enough that it sits close to neck of the vial, making the fluid bolus 
more accessible. It was found that the larger dead space in the spike vial adaptor caused problems 
when attempting to withdraw the total volume of medication from vials containing 2 mL or less 
of fluid. Additionally, the diameter of the spike-vial adaptor was so large that, in some instances, 
it totally displaced the septum of the vial, causing leakage and risk of drug contamination. 
 
Learning points from the study: 
1. Air injection into a vial makes air/fluid isolation for withdrawal challenging. 
2. Medication withdrawal from a vial requires three distinct steps: fluid isolation in vial, fluid 
withdrawal from vial, and fluid isolation in syringe to achieve final medication volume for 
injection. These distinct steps should be emphasized in procedure documentation and training 
practices. 
3. Fluid viscosity is not a limiting factor in vial adaptor selection. 
4. Medications evaluated within this flight do not present issues with particulates or disabling 
foaming properties within the microgravity environment. 
5. When reconstituting medications from powder, it is suggested that a lower concentration and 
higher volume should be considered for ease in medication withdrawal into a syringe. This 
study evaluated 3 volumes of ceftriaxone diluted with lidocaine or a normal saline solution. 
 
Limitations of the study: 
1. Aircraft cabin pressure was reported to be variable during flight but averaged approximately 
7 psi. ISS cabin pressure has a higher range of 10.7 psi to 15.2 psi 
2. Parabola length was too short to evaluate all of the steps required to withdraw medications 
from a vial, taking into consideration fluid bubble management. These steps are required in 
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full sequence in microgravity to fully assess the time impact required to withdraw the 
medications. Microgravity portions of parabolas were also variable and unpredictable. 
3. Bubbles and microbubbles that could be formed during the agitation of launch and 
subsequent continuous microgravity could not be realized in this study due to the pullouts. 
4. Difficulty in shipments prior to flight eliminated the testing of the blunt cannula-vial adaptor. 
It is felt that this hardware should be given consideration in a future reduced-gravity flight 
due to its low volume of dead space, small packaging size, and ability to be manipulated 
within the vial. 
5. It was desired to have a second day of flight to evaluate parameters assessed on this first 
flight and modify testing procedures using lessons learned. 
 
Future studies: 
It is desired that a future flight be scheduled to evaluate the cap-vial adaptor against the blunt 
cannula, especially as it relates to use of single-dose vials compared with larger-volume multi-dose 
vials. An additional flight would be used to further refine the procedure steps required for fluid 
isolation, with focus specifically on fluid isolation within a syringe. 
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GOALS 
This test was a continuation of the Constellation Program (CxP) Extravehicular Activity 
(EVA) Systems Project Office (ESPO- sponsored testing series that is being conducted to enable 
the development of optimized design requirements for the next-generation lunar EVA suit. ESPO 
initiated this series of tests aimed at understanding human performance and suit kinematics under 
a variety of simulated lunar EVA conditions. The test series is a collaborative effort among the Crew 
and Thermal Systems Division (CTSD), the EVA Physiology, Systems, and Performance (EPSP) 
Project, the Anthropometry and Biomechanics Facility (ABF), and the Exercise Physiology and 
Countermeasures (ExPC) Project of the HACD. The goal of the studies is to systematically eval-
uate the individual contributions of suit weight, mass, center of gravity (CG), pressure, and kine-
matics and determine their relative contributions to the overall metabolic cost, biomechanics, and 
required operator compensation associated with performing ambulation and exploration tasks in 
spacesuits. 
 
OBJECTIVES 
The objectives of this study in the testing series were to: 
 
1. Compare the results to testing performed on the NASA JSC prevention of coupled structure 
propulsion instability (POGO) partial-gravity system during Integrated Suit Test (IST)-1 and 
IST-2. 
2. Assess the effects of varying the suit weight while keeping CG and mass constant. 
3. Assess the effects of varying the suit mass while keeping CG constant. 
4. Assess the effect of varying the suit CG while keeping mass and weight constant. 
 
METHODS AND MATERIALS 
The study protocol was designed to evaluate the objectives through subject performance of 
ambulation and exploration tasks similar to those performed during prior POGO tests.  The 
protocol for the study was reviewed and approved by the NASA JSC Committee for the 
Protection of Human Subjects. Subjects were provided written informed consent and a layman’s 
summary before participating in the study. Seven astronaut subjects took part in the study, with 
subjects nominally flying 3 times to complete all conditions. Data were collected during 14 
flights, with each flight consisting of approximately 60 parabolas. Two flights were designated as 
engineering flights to ensure the efficacy of the planned protocols and data collection techniques. 
Testing was performed both unsuited and suited. The suited portions of the test used the Mark III 
Advanced Space Suit Technology Demonstrator (MK-III). 
 
The tasks performed were walking, kneeling and recovering, shoveling, and rock pickup (figure 
1). The test conditions consisted of 3-suit masses (195 lbs, 265 lbs, and 400 lbs assessed at zero-
G to 17-G and a constant CG), 3-suit weights (simulated by 0.1-G, 0.17-G, and 0.3-G parabolas 
at a constant suit mass of 265 lbs and a constant CG), and 3 CGs (1 being near a standard 
subject’s natural CG and 2 further high and aft, all assessed at 400 lbs and 0.17-G; figure 2). A 
matrix of the test conditions is shown in Table 1. 
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Figure 1. Subjects performing study tasks; clockwise from top left: walking,  
kneeling and recovering, shoveling, and rock pickup. 
 
 
Figure 2: Subject performing rock pickup task with mass/CG rig configured for different CGs; arrows point to  
differences in position of weights on rig in each configuration; left to right: backpack, CTSD, and POGO CG. 
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Table 1. Matrix of Test Conditions 
Suit Mass 195 lbs 265 lbs 400 lbs
g-level 0.17-g 0.17-g 0.17-g
1-g Suit Weight 195 lbs 265 lbs 400 lbs
CG ~CTSD ~CTSD CTSD
Suit Mass 265 lbs 265 lbs 265 lbs
g-level 0.1-g 0.17-g 0.3-g
1-g Suit Weight ~87 lbs 265 lbs ~620 lbs
CG ~CTSD ~CTSD ~CTSD
Suit Mass 400 lbs 400 lbs 400 lbs
g-level 0.17-g 0.17-g 0.17-g
1-g Suit Weight 400 lbs 400 lbs 400 lbs
CG Backpack CTSD POGO
Varied Mass Testing
Varied Weight Testing
Vaired CG Testing
Note: Red and green matching denotes the same condition; those conditions are 
shown twice for descriptive purposes only; the condition was only performed 
once across Phase I & Phase II
 
For each tested condition, the walking task was performed during 4 parabolas, shoveling for 2 
parabolas, rock pickup for 2 parabolas, and kneeling and recovering for 1 parabola. During a 
parabola dedicated to a particular task, the task was nominally performed twice. 
 
Motion-capture camera systems were used along with biomechanics markers to capture the gait 
characteristics and kinematics of the subjects as they performed tasks. Force plates also were 
used to collect vertical ground reaction force during walking and to provide input for determina-
tion of stability while performing the shoveling and rock pickup tasks. Since the duration of 
parabolas does not allow for accurate direct metabolic rate measurement, subjective ratings of 
perceived exertion (RPEs) were collected. Results from the ground-based series of tests on the 
POGO produced a correlation between RPE and metabolic rate that can be used for metabolic 
rate estimations. Finally, ratings of modified Cooper-Harper (CH) were collected to determine 
the amount of operator compensation required for the subjects to perform the task. The modified 
CH scale allows subjects to be their own control as ratings are given in reference to their own 
ability to perform the task in a 1-G shirtsleeve environment. 
 
RESULTS 
The results of this study are being assessed at the time of this publication. Efforts are under way 
to address the objectives through analysis of the collected data and comparison of the results to 
those from the EVA Walkback Test, ISTs-1, -2, and -3, as well as Neutral Buoyancy Laboratory 
(NBL) and NASA Extreme Environment Mission Operations (NEEMO) (9–13) tests. 
 
DISCUSSION 
This test series is developing a parametric understanding of the interrelationships among suit 
weight, mass, pressure, and CG as well as crew anthropometrics and performance while defining 
the limitations and correction factors associated with each testing environment. This test was 
designed to validate earlier testing performed on the POGO and to provide guidance for the 
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design of other reduced-gravity simulator projects such as the Active Response Gravity Offload 
System (ARGOS). The results will also provide new insights into the effects of CG on suited 
performance. The outcomes of this testing series will contribute to the development of informed, 
evidence-based recommendations for suit weight, mass, CG, pressure, and kinematic constraints 
that optimize human performance in partial-gravity environments. 
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GOAL 
It has been determined during the past decades of space travel that the human immune system is 
compromised during extended periods in the environment of orbital flight. The goal of our 
research was to determine what effect the force of gravity has on the rate at which immune 
complexes are formed. 
 
OBJECTIVES 
We considered the following question for our principal investigation with this project: “What is 
the dependency, if any, of immune complex formation rates on gravitational force?” We hypothe-
sized that gravitational forces would change the convection flow within the fluid, thus preventing 
the immune molecules from interacting the way they normally do. Thus we predicted that the 
reaction rate would decrease in a reduced-gravitational environment due to less molecular inter-
action. In an attempt to prove our hypothesis, our research group, The Weightless Lumbee’s from 
The University of North Carolina at Pembroke, conducted a human immune complex formation 
reaction in the zero-G portions of the parabolic flight path flown by the NASA research aircraft. 
The reaction rates from these flight samples were then compared to ground-truth experiments. 
 
METHODS/MATERIALS 
To study the formation of immune complexes in vitro, we observed the reaction between human 
immunoglobulin G (IgG) and goat-derived anti-immunoglobulin G (A-IgG) in a sodium 
phosphate buffer. 
 
In a laboratory setting this reaction would be monitored for a period of several minutes to 
determine the rate of increase in the absorbance. However, due to the limited period of zero G on 
board the research aircraft, we had to find a way to accelerate the reaction rates. We wanted to 
have an absorbance change of approximately 0.15 to 0.20 over the first 20 seconds of reaction. 
To accomplish this we employed a buffer solution containing polyethylene glycol (PEG) that 
served as a catalyst to break down the structure of the water molecules and increase the rate of 
reaction. After trying a wide range of concentrations, it was determined that a PEG concentration 
of 7.5 mM added to the sodium phosphate buffer yields optimal absorbance during the 20-second 
interval at a wavelength of 280 nm. Consequently, a 7.5 mM solution of PEG and sodium phosphate 
was used to create the buffer solution in which the technical-grade IgG and the A-IgG would 
react to form immune complexes. The rate of absorbance for our optimal concentration is shown 
in figure 1. At this concentration, we achieved an absorbance change of 0.15 during the first 20 
seconds of reaction. Another factor that became apparent during the initial phases of our work 
was the effect that massaging (i.e., pulling the combined fluid back into the syringe and re-
injecting it into the cuvette) has on the uniformity of the reaction. Without massaging, the data 
were very oscillatory and non-repeatable. With only 2 massages using both syringes (see the 
equipment description below), we found a significant increase in the linearity of our data, and the 
results were consistent from one run to another. 
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Figure. 1. Absorbance rate from the preliminary experiments to determine optimal PEG concentration.  
A 7.5 mM PEG buffer was found to provide an acceptable rate of reaction. 
 
To measure the rate at which the complexes formed after both the IgG and the A-IgG solutions 
had been combined, we used an Ocean Optics CHEMUSB4-UV-VIS consisting of a USB4000 
spectrometer with a combination deuterium tungsten halogen light source and a 1-cm cuvette 
holder interfaced with a PASCO Xplorer GLX Graphing Datalogger. This assembly was used to 
record the absorption measurements of both the zero-G flight data and the 1-G ground-truth data. 
 
 
Figure 2. Front and inside view of the double-wall Lexan® glove box with two sets of industrial-strength rubber gloves. 
The glove box is shown with video camera mounting bar and top both removed. 
 
While in flight, the experiment apparatus was housed in a double-walled Lexan® glove box, 
which allowed access by heavy-duty industrial-style rubber gloves (see figure 2). The immune 
complex formation (ICF) apparatus was constructed using two 1-mL syringes secured to a 
wooden piece by a retaining block (see figure 3). Each syringe had a 26-gauge needle secured to it. 
The two needles punctured a plastic cap that was sealed to a standard CVD-UV plastic  
1 cm×1 cm×4.5-cm (4.5-mL) cuvette. The top of each cuvette was secured to the wooden piece 
by an aluminum retaining strip. Each ICF apparatus was secured vertically onto an ICF holder 
using industrial style Velcro®. Between each zero-G portion of the parabolas, 1 ICF was removed 
from the ICF holder and placed within the spectrophotometer. The IgG and A-IgG were mixed 
into the cuvettes, which contained the PEG buffer solution, on entering the zero-G portion. The 2 
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syringes were operated simultaneously, massaging the solution twice, and the absorption was 
recorded over the approximately 20-second zero-G period. We were able to acquire 5 usable runs 
on the first flight day and 7 usable runs on the second day. There were 2 primary reasons why we 
did not have more successful data: (1) the primary experiment operator on each day experienced 
motion sickness within the first 10 parabolas, and (2) the team experienced equipment 
malfunctions that required valuable flight time to correct. 
 
 
 
Two 0.5 mL 
syringes 
 
Syringe retaining 
block 
 
Sealed cap with 
two syringe 
needles 
penetrating. 
Needles and cap 
will be secured 
   
Retaining strip 
 
1 cm x 1 
cm x 4.5 
cm cuvette 
  
Figure 3. Immune complex formation apparatus. 
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 (a) (b) (c) 
Figure 4. Absorbance as a function of time for two typical measurements: (a) 1-G ground-truth sample, (b) zero-G flight 
sample, and (c) both samples plotted together; (c) clearly shows the difference in absorbance rates measured in the 
two gravitational fields. 
 
The ground-truth samples were measured in the laboratory postflight using the same equipment, 
concentrations, and procedures as during the flight. Figure 4(a) shows the absorbance as a func-
tion of time for a single representative run from the 1-G ground-truth samples. The start time 
 73 
shown, set as zero, corresponds to the time period after the massaging process. Since the zero-G 
portion of each parabola was approximately 20 seconds, we only fit the absorbance rate over the 
same approximate range. The average rate change in the absorbance for all ground-truth data was 
0.0101 s-1. Figure 4(b) is a plot of absorbance versus time for a typical measurement made in 
zero G. The average rate change in the absorbance for all flight samples was 0.0122 s-1. The data 
shown in figures 4(a) and 4(b) were chosen because their slope is close to the average values 
quoted above. These same 2 runs are plotted together in figure 4(c). 
 
From figure 4, we see that one of our initial goals was achieved; that is, a reasonable total 
increase in absorbance over the first 20 seconds of each measurement was achieved. For the 1-G 
data, we measured an average change in absorbance of 0.19 over an average period of 16.8 
seconds. This extrapolates out to a change of 0.23 over a period of 20 seconds. The flight data 
exhibited an even greater rate, with an average change in absorbance of 0.22 over an average 
period of 15.5 seconds. This projects out to a change of 0.28 over 20 seconds. 
 
While the slopes of the curves are small values, there is a distinct change. This is convincingly 
shown in figure 4(c), where the 2 absorbance rates, 1 G and zero G, begin at approximately the 
same level but clearly diverge, with the zero-G measurements increasing at a faster rate than the 
ground-truth ones. The average slope value for the zero-G data is almost 21% larger than the 
average value for the 1-G data. 
 
A concern of the group, when initially looking at the data, was the fact that we obtained negative 
values for the absorbance. The negative values were obtained during the second flight day and 
during the ground-truth measurements. We believe that this is due to a calibration error during the 
initial “dark” and “blank” scans. This has not been verified yet, but we still have confidence in 
the data since (1) our interest is in the change in the absorbance, not the absolute values; and (2) 
the data taken on the first flight day, which had positive absorbance values, had approximately 
the same slope values and changes in absorbance over the periods of interest as did the data with 
negative absorbance readings. 
 
Overall, the greater slope of the zero-G absorbance data was a surprise to us as we initially 
expected to find a faster rate of reaction in the 1-G samples. At this time, we are trying to 
understand the mechanisms that could be responsible for the difference. Our initial conclusion is 
that the convection currents within the solution, present in the 1-G measurements, act to hinder, 
rather than enhance, the IgG/A-IgG reaction rate. 
 
CONCLUSION 
In this experiment we attempted to investigate the effects of microgravity on the immune system 
by looking at the binding rates of antigens and antibodies found in the human body. This was 
accomplished by measuring the absorbance rate of the reaction between human IgG and goat-
derived A-IgG in a sodium phosphate buffer. The identical experiment was performed in zero G 
and 1 G to determine whether there is a gravitational effect on the rate of reaction. Our data 
clearly show a faster rate of absorbance, and, hence, a faster rate of reaction between the IgG and 
A-IgG in the zero-G environment versus the 1-G laboratory setting. We are continuing with this 
line of research and plan to repeat the 1-G measurements in the near future. The team also hopes 
(c) (a) 
(b) 
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to have the opportunity to repeat the zero-G measurements on board the NASA parabolic flight 
aircraft. In addition to repeating the zero-G data, we hope to make measurements in the 0.38-G, 
1.62-G, and 1.8-G environments available to see whether we can confirm our conclusion of a 
decreased reaction rate in an increased gravitational field. 
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GOAL 
The purpose of this experiment was to examine how spatial awareness is impaired with changing 
gravitational cues during parabolic flight, and the extent to which vibrotactile feedback of 
orientation can be used to help improve spatial awareness. 
 
OBJECTIVES 
Our first objective was to examine how spatial navigation was impaired during parabolic flight. 
We hypothesized that one’s ability to report one’s orientation and point toward targets around 
one would be impaired during the microgravity phase of parabolic flight compared to 1-G control 
trials obtained on the ground. Our second objective was to examine how vibrotactile cueing of 
down relative to the aircraft improved spatial navigation. We hypothesized that tactile cueing 
would provide an effective gravitational substitute during the microgravity phase of parabolic 
flight that would improve spatial navigation ability. A third independent objective was to ex-
amine the overall shape of the heart and blood flow velocity in the left ventricle in response to 
changes in gravitational loading using portable echocardiography. We hypothesized a 
proportional increase in the sphericity of the left ventricle as a function of G-load. 
 
METHODS AND MATERIALS 
Spatial navigation requires an accurate awareness of orientation in one’s environment, and then 
executing the appropriate motor behavior towards locations of interest. In this experiment we 
assessed spatial navigation by asking subjects to virtually point to remembered target locations 
around them. Subjects were restrained in a tilted position and placed at random positions ranging 
from nose up to nose down relative to the plane floor. Once placed in a new orientation, a target 
position was presented using a virtual-reality video mask. Subjects reported their orientation 
using verbal reports, and used a handheld controller to point to the desired target location. This 
spatial navigation task was repeated during the microgravity phases with and without constant 
tactile cueing of spatial vertical. The tactile cueing used a belt of 8 tactors placed around the mid-
torso. The tactors closest to the floor of the plane were activated to indicate which direction was 
“down”. Control measures were obtained during ground-testing so that spatial navigation 
performance during microgravity with tactile cueing could be compared with 1-G runs without 
tactile cueing. 
 
Echocardiography measures: The effect of different levels of gravity on the size, shape, and 
function of the left ventricle was assessed with echocardiography using a 5-1 MHz phased array 
transducer (Philips Medical CX50, Andover, MA) during microgravity, lunar, and Martian phases 
of parabolic flight. Apical 4-chamber views and Doppler images were acquired with the subjects 
in the upright seated position, and images were stored on DVD. Analyses were performed 
postflight using off-line software (Q Lab, Philips Medical, Andover, MA) to determine left 
ventricular size and function. 
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RESULTS 
Perceptual errors in verbal reports of position increased with increasing chair displacement 
without tactile cueing, based on the analysis to date. This is consistent with postflight debriefings 
in which the subjects indicated difficulty in maintaining spatial awareness for displacements 
larger than 45 degrees. Interestingly, the perceptual errors during microgravity were not 
consistently different than those that occurred while performing the task about an upright 
orientation on Earth. In contrast, perceptual errors of body orientation were negligible when the 
task was performed about a tilted axis on Earth, or during microgravity with tactile cueing of 
orientation. The perceptual errors in body orientation were correlated with errors in pointing to 
virtual targets. There were no significant differences in the time required to point toward the 
virtual targets across conditions. 
 
Echocardiography measures: There was a close correlation between the circularity of the left 
ventricle (sphericity in a single plane) and the degree of gravitational force directed caudal to the 
longitudinal orientation of the body. Ejection time was inversely proportion to gravitational load. 
 
DISCUSSION 
Spatial navigation requires an accurate awareness of orientation in one’s environment, and then 
execution of the appropriate motor behavior toward locations of interest (Benson, 2003). On 
Earth, low-frequency otolith and somatosensory neural activity provides information regarding our 
orientation relative to gravity. This sensory input is used by the central nervous system to maintain 
awareness of orientation and movement relative to a stable gravitoinertial reference frame. The 
absence of this input during microgravity can lead to perceptual illusions (e.g., inversion illusions) 
and impair one’s ability to navigate within an orbiting spacecraft (Aoki et al., 2007). The micro-
gravity phase of parabolic flight sequence provided a unique capability to assess spatial navigation 
capability without the normal gravity-receptors (e.g., otoliths, somatosensors) that are important 
for spatial orientation on Earth. We hypothesized that spatial awareness would be impaired 
during the microgravity phase of parabolic flight. This experiment also tested the extent to which 
tactile cueing of spatial vertical can be used to substitute for altered gravity-receptor input. The 
Tactile Situation Awareness System (TSAS) was developed in the U.S. Navy as a means of 
providing orientation information during altered sensory conditions in both helicopters and fixed-
wing aircraft (Rupert, 2000). TSAS consists of a matrix of electromechanical tactile stimulators 
applied on the torso that can be used to convey orientation cues to the skin, such as an individual’s 
position relative to gravity. We hypothesized that tactile cueing will provide an effective grav-
itational substitute during the microgravity phase of parabolic flight that will improve spatial 
navigation ability. 
 
Our results demonstrated increased perceptual errors of tilt orientation and pointing errors during 
passive motion in microgravity or movements about an Earth-vertical axis, especially when these 
movements were greater than 45 degrees. In either case, cues from the otoliths and other 
somatosensory cues of gravitational loading were negligible. This demonstrates the importance 
of these gravitational sensors for maintaining spatial awareness on Earth, and the risk for losing 
awareness during transient periods of weightlessness with reduced visual information regarding 
one’s surroundings. The lack of any differences in latency to point to targets was likely due to the 
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instruction set to perform the task “as quickly and accurately as possible”. The perceptual errors 
of body orientation carried to errors in pointing toward virtual targets without affecting the speed 
at which subjects navigated to the new orientation. 
 
These perceptual errors were reduced during movement about a tilted axis on Earth, indicating 
the importance of otolith and other somatosensory cues for maintaining spatial awareness. Since 
the perceptual errors were similarly reduced during microgravity trials with tactile cueing, the re-
sults are consistent with our hypothesis that vibrotactile cueing of down relative to the aircraft 
improves spatial navigation. 
 
CONCLUSION 
These results indicate that tactile cueing may improve navigation in operational environments, 
such as EVAs on a lunar surface. This type of sensory feedback may also prove beneficial as a 
navigation aid in patient populations, providing non-visual, non-auditory feedback of orientation 
or desired direction heading. 
 
REFERENCES 
1. Aoki H, Oman CM, Natapoff A. Virtual-reality-based 3D navigation training for emergency 
egress from spacecraft. Aviat Space Environ Med; 78:774–783, 2007. 
2. Benson AJ. Spatial disorientation - general aspects. In: Ernsting J, Nicholson AN, Rainford 
DJ (eds) Aviation Medicine. Arnold, London, pp. 419–436, 2003. 
3. Rupert AH. Tactile situation awareness system: proprioceptive prostheses for sensory 
deficiencies. Aviat Space Environ Med; 71:A92–99, 2000. 
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GOAL 
The primary goal for this experiment was to measure the transpiration rate of a plant in a zero-G 
environment and determine if the rate differs from that in a 1-G environment. 
 
OBJECTIVES 
The objectives for this experiment were to measure plant transpiration in zero-G, 1/6-G (lunar), 
and 1/3-G (Martian) reduced-gravity environments by means of relative humidity (RH) and use 
these measurements to determine the transpiration rate. 
 
METHODS AND MATERIALS 
A plant transports water from its root system to other parts of the plant through a process called 
transpiration. If a root is sitting in a solution containing inorganic ions and water, the root cells will 
pump the ions into the xylem, producing a hypertonic solution inside the xylem. The cell walls of 
the plant are permeable to water and, due to the newly formed concentration gradient between the 
xylem and its exterior, water moves into the xylem by osmosis. The water in the xylem is pushed 
up a short distance by root pressure, but the primary mode of transportation is transpiration. 
Transpiration occurs when a water molecule leaves the leaf through a stoma. The cohesion of 
water molecules, by hydrogen bonding, forms a chain of water molecules from the stomata, 
through the xylem, down to the root system. A concentration gradient forms between the inside 
of a leaf and the surrounding air when the leaf contains more water than the air. When a stoma 
opens, a water molecule will be pulled off from the chain due to diffusion. The tension caused by 
this pulls the other water molecules in the chain up through the xylem. The question addressed in 
this experiment was whether gravity affects the rate of transpiration. 
 
The experiment was performed using the transpiration chamber shown in figure 1. The chamber 
is constructed with 4 separable parts: the lower chamber, the inner chamber, the upper chamber, 
and the chamber attachment. 
 
 
Figure 1. Transpiration chamber. 
 
The lower chamber is a rectangular polyethylene container (4.75 in×4.625 in×7.25 in) glued to a 
rectangular acrylic board (15 in×10 in×0.1875 in). A TI-84 calculator (used as a data logger) was 
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attached to the board using Velcro®. The inner chamber is a cylindrical-polyethylene container  
(3 in×5.5 in). A one-hole rubber stopper is sealed into its neck using silicon caulking. The upper 
chamber is a rectangular polyethylene container (5.5 in×5 in×10 in). A Vernier RH sensor is pushed 
through a 1-hole rubber stopper and into a hole in the top of the container. A battery-powered 
electric fan is sealed into a hole on the left side of the container using silicon caulking, and a 
removable solid rubber stopper is in a hole on the right side. The chamber attachment consists of 
2 lids fit the lower and upper chambers. The lids are glued top to top, and a 1-hole rubber stopper 
is sealed into a hole through the lids using silicon caulking. 
 
The plant was pushed through the rubber stopper in the chamber attachment and the rubber 
stopper in the inside chamber. Silicon caulking and duct tape were used to seal the plant into both 
stoppers. This process provided double containment of the water in the inside container. 
 
On the first flight (January 15, 2009), we collected RH samples for 18 zero-G parabolas, three 
1/6-G parabolas, and two 1/3-G parabolas using the Vernier RH sensor and the TI-84 calculator. 
Each reduced-gravity portion of a parabola lasted approximately 18 seconds. The following steps 
were followed for each parabola: 
 
1. If the fan is off, turn it on at the beginning of the reduced-gravity maneuver. 
2. Seal the upper chamber with the solid rubber stopper at the beginning of the reduced-gravity 
maneuver. 
3. Start the data log program on the TI-84 calculator. The program was configured to take one 
sample per second for 18 seconds. 
4. At the end of the reduced-gravity maneuver, unseal the upper chamber. 
5. Run data transfer program on the calculator to prepare it for the next reduced-gravity 
maneuver. 
6. Turn the fan off if the RH drops too low. 
 
On the second flight (January 16, 2009), we collected RH samples for 18 zero-G parabolas, three 
1/6-G parabolas, and six 1/3-G parabolas using the Vernier RH sensor and the TI-84 calculator. 
Each reduced-gravity portion of a parabola lasted approximately 18 seconds. The fan was never 
turned off, and the upper chamber was sealed the entire time. The following steps were followed 
for each parabola: 
 
1. Start the data log program on the TI-84 calculator. The program was configured to take one 
sample per second for 18 seconds. 
2. Run data transfer program on the calculator to prepare it for the next reduced-gravity 
maneuver. 
 
The changes in procedures from the first to the second flight were due to a change in environ-
mental conditions that were outside of our control. 
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RESULTS 
The change in RH was determined by the difference of final RH and initial RH: 
 
if RR − . 
 
The change in time was always 18 seconds. The average rate of transpiration was determined by 
the ratio of change in RH by change in time: 
 
18
if RRARC
−
= . 
The following bar graph displays the zero-G trial data obtained on the first flight: 
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The average rate of change for each trial is shown in the following bar graph: 
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The mean rate of transpiration was 0.1376 ± 0.0190 %RH/sec. 
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The following bar graph displays the trial data obtained at Ellington Field (1 G) before the first 
flight: 
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The average rate of change for each trial is shown in the following bar graph: 
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The mean rate of transpiration was 0.13333 ± 0.0193 %RH/sec. 
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The trial data for lunar and Martian gravity on the first and second flights are shown in the 
following bar graphs: 
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DISCUSSION 
We compared the mean rates of change of RH in zero G and 1 G using the trial data obtained 
during the first flight and the trial data obtained at Ellington Field. We let the null hypothesis be 
that the average rate of change of RH in zero G is the same as that in 1 G, 100 : µµ =H . The 
alternative hypothesis was set up to be 10: µµ >aH . Using a 2-sample t-test, we decided that the 
null hypothesis could not be rejected at a 95% confidence level. 
 
CONCLUSION 
The goal for this experiment was to measure the transpiration rate of a plant in a reduced-gravity 
environment. Based on our analysis, gravity appears to have no effect on the rate of transpiration 
within 18 seconds. 
 
REFERENCES 
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INTRODUCTION 
In February 2003, President George W. Bush declared the new vision for the U.S. space program. 
He directed NASA to refocus its efforts and resources toward Exploration-class missions 
(Wikipedia, 2003). This vision involves completion of the ISS and retirement of the space shuttle 
by the year 2010, and the development of new vehicles and hardware to return humans to the Moon 
by 2020. The U.S. also plans to send humans to Mars. To fulfill this vision, NASA is using 
lessons learned from previous exploration programs and experience from long-duration missions 
on the ISS to design systems that will enable safe human exploration in these reduced-gravity 
environments. 
 
Experience from long-duration spaceflight on board Skylab, the Russian space station Mir, and the 
ISS demonstrates that exposure to microgravity causes a variety of detrimental physiologic 
changes to the human body (Baldwin et al., 1996), including loss of bone mineral density, skeletal 
muscle, and aerobic capacity. After only 4 days of spaceflight, catabolic bone markers are increased 
(Smith and Heer, 2002), and after 14 days, losses of muscle cross-sectional area occur (Leblanc 
et al., 1995). Longer-duration exposure to microgravity results in bone remodeling with significant 
losses of bone mineral density in the weight-bearing areas of bones (i.e., the calcaneus, greater 
trochanter, femoral neck, and pelvis) (Organov et al., 1997). Losses of muscle mass and neuro-
muscular disturbances result in decreases in muscular strength (Baldwin, 1996) and endurance 
(Hayes et al, 1991). Aerobic capacity is also compromised during spaceflight due to changes in 
blood volume and aerobic deconditioning (Trappe et al., 2005). 
 
These physiologic changes will be hazardous to humans, especially when working in the 
reduced-gravity environments of the Moon and Mars. Decreased bone density in weight-bearing 
bones could result in fractures, which is problematic considering the limited medical support that 
will be available during these missions. Loss of aerobic capacity, muscle strength, and endurance 
could inhibit an astronaut’s ability to perform EVAs that may require several hours of high 
metabolic activity. 
 
Space-suit design is a critical element of human space exploration. The challenge of returning 
humans to the moon by 2020 has necessitated the development of a new space-suit system that 
will enable efficient and effective movement on the lunar surface during EVA. This space-suit 
system consists of the pressure garment and life support subsystems, each of which have their 
own unique design challenges. 
 
Designs for the Portable Life Support System (PLSS) for lunar exploration have gone through 
several iterations. The focus of recent design efforts has been on packaging the thermal, ventila-
tion, and oxygen subsystem components, with emphasis on mass and volume reduction for the 
overall architecture, as well as optimization of the center of gravity (CG). Figures 1 and 2 
illustrate the PLSS-package design, including overall mass and volume data, as presented to 
NASA management in April 2008 (Thomas, 2008). 
 
While the safety of the astronaut is of utmost importance in the design of a space-suit system, 
there is a significant human performance element as well. It is essential to understand the 
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biomechanical consequences of changing the PLSS-CG location to speculate on the potential for 
injury and/or the rising metabolic demand associated with each CG location. With previous 
evidence suggesting that humans lose bone, muscle, and aerobic capacity in microgravity envi-
ronments, these data will be important to understand the potential forces that could be imparted 
to the skeletal system during suited EVAs. Additionally, because human physiology adaptations 
are specific to imposed physical demands, it may be necessary for crewmembers to perform loco-
motive exercise with simulated gravitational force acting on their bodies to prepare for work on 
the surface of the Moon and Mars while in transit to these destinations. 
 
Therefore, the proposed research quantified the effect of varying CG location of the PLSS on 
locomotive biomechanics in lunar and Mars reduced-gravity environments. Comparisons were 
also made of the lunar and Mars data to microgravity test conditions in which CG was also varied, 
but resistance bands with a force equivalent to 1/3 G and 1/6 G times the subject’s body weight 
were attached to the test subject and test equipment. 
 
 
Figure 1. Location of PLSS CG and total PLSS mass in 1 G. 
 
 
Figure 2. PLSS volume envelope. 
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Experiment Description 
The primary purpose of this research was to quantify the biomechanical responses for 2 PLSS-
CG locations at a 0% incline on a treadmill (Life Fitness 95Ti) in the reduced-gravity 
environment. The secondary purpose of this investigation was to quantify the biomechanics in 
microgravity with a resistance force equal to 1/3 G and 1/6 G while altering CG location for 
comparison to the lunar and Mars parabolic conditions. 
 
A backpack, the “PLSS simulator” (figures 3 and 4), designed to simulate the total lunar volume 
of the PLSS, was worn by a test subject walking on a treadmill. Six weight bags (figure 5) were 
placed in the back and left pockets of the PLSS simulator to represent a CG offset to the 
respective location. Reflective markers were attached to the test subject’s knees, ankles, and neck 
with double-sided tape. A camera videotaped the test subject’s movement during parabolic flight; 
the resultant video was used for postflight evaluation of hip and knee joint angles. By varying the 
CG and evaluating the biomechanical changes, this research will help NASA make smarter 
design decisions for future development of the PLSS package. It may also provide input 
concerning the potential harmful effects of changing CG location during ambulation. 
 
 
Figure 3. PLSS simulator: side view, back view, and front view. 
 
    
Figure 4. PLSS simulator on test subject.    Figure 5. Weight bags for CG loading. 
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Hypotheses 
This research quantified the effect of changes in the location of the CG of the PLSS on a test 
subject’s movement at the trunk and lower extremities. The normal CG location is in line with 
the shoulders, hips, and knees when standing straight, and is typically located near a person’s 
navel. When wearing a backpack, however, the CG shifts posterior, causing the person to alter 
biomechanics to compensate. Most guidelines indicate that backpacks should be packed such that 
the CG stays low and close to the hips, but with space-suit-PLSS design that may not be possible 
due to packaging constraints associated with enclosing heavy, large life-support components in a 
sturdy frame. In this test, since the weight of the simulated PLSS remained constant, the variation 
of the CG location may cause the test subject to compensate with altered biomechanics while 
walking on the treadmill. In addition, it was expected that the reduced-gravity environment would 
cause the test subject to compensate to a greater degree compared to 1-G testing. Finally, we 
expected that the locomotive biomechanics during treadmill exercise in microgravity with re-
sistance bands to differ from the same exercise conditions in lunar and Mars parabolic flight. 
 
Experiment Methods 
During the reduced-gravity flight, biomechanics were measured for 2 CG locations at a treadmill 
incline of 0%. The 2 CG locations (back and left) were selected based on results from the UHCL 
1-G testing conducted in the autumn of 2008. The 1-G testing evaluated 7 CG locations [center 
(unweighted PLSS simulator), top, bottom, left, right, front, and back]. The treadmill walking 
speed was set to 1.8 mph, which was the average walking speed that would have been required if 
the rover failed over 6 miles from the habitat and the crewmembers had needed to walk back 
during the Apollo missions. 
 
The test subject wore tight-fitting clothing (i.e., compression tights, a sports top, and athletic 
shoes) that did not restrict body movements during testing. Reflective markers were attached to 
the test subject via double-sided tape bilaterally at the following locations: lateral malleolus, knee 
joint line, tibial tuberosity, and neck. 
 
While wearing a backpack designed to simulate the total lunar volume of the PLSS, the “PLSS 
simulator”, the test subject walked on a treadmill at 1.8 mph during parabolic maneuvers. The CG 
location of the subject was altered by repositioning the mass within the PLSS simulator via 
weight bags. Video data were collected continuously during ambulation by 1 video camera on the 
left side of the treadmill. Video footage was evaluated postflight using 2-dimensional motion 
capture software (Dartfish). The software was used to analyze the collected video data by 
comparing joint kinematics across the different CG and resistance levels. 
 
During the microgravity parabolas, the subject was tethered to the treadmill using modified 
surgical tubing resistance bands. Prior to flight, load cells were used to determine the length of 
tubing necessary to create a force equal to 1/6 and 1/3 times the subject’s body weight. The data 
collected during the microgravity parabolas were compared to the lunar and Mars parabolas, 
where the test subject was untethered. 
 
Real-time data collection from the test subject also included rating of perceived exertion (figure 
6). These values were used to analyze the qualitative effects of varying CG for each test subject 
at each test condition. 
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Exertion Rating 
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Figure 6. Borg RPE scale (Adams and Beam, 2008). 
 
RESULTS/DISCUSSION 
Results of this research have been subdivided into 5 research areas, resulting in 4 abstracts for the 
2009 UHCL 14th Annual Student Conference for Research and Creative Arts and 1 poster 
presented at the 2009 American Society of Exercise Physiologists (ASEP) national conference in 
Tyler, Texas. The following sections provide these results. 
 
Research Area 1 
Lower-extremity Kinematics in Terrestrial and Simulated Lunar Conditions 
Purpose: The purpose of this research was to quantify lower-extremity and trunk biomechanics 
during terrestrial and simulated lunar ambulation with 2 center-of-mass (COM) locations. 
 
Hypotheses: 
1. When ambulating on a treadmill in simulated lunar gravitational conditions, stride length is 
increased compared to ambulation on Earth. 
2. Shifting the COM to the back results in an increased knee and trunk angle in lunar 
gravitational conditions compared to Earth. 
3. Shifting the COM to the side does not alter knee or trunk angle in lunar gravitational 
conditions compared to Earth. 
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Methods: Stride length was measured at left heel strike, and knee and trunk angles were analyzed 
during the mid-stance phase of gait using 2-dimensional motion capture software. Differences in 
means and effect sizes (Cohen’s d) were calculated. Large differences were observed in the knee 
angles (0.63 deg, d=0.20) and trunk angles (14.70 deg, d=1.57) when comparing Earth gravity (Eg) 
and lunar gravity (Lg) in the back COM condition. Differences were observed for the left 
COM: knee angle (5.49 deg, d=1.11) and trunk angle (8.60 deg, d=1.40). Variations were also 
observed in stride length under both conditions: back (0.10m, d=1.45) and left (0.17m, d=2.12). 
 
 
Figure 7. Trunk flexion angle at mid-stance phase. 
 
 
Figure 8. Knee flexion angle at mid-stance phase. 
 
Figure 9. Variation in stride length. 
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Table 1. Differences in Stride Length, Knee Angle, and Trunk Angle in  
Simulated Lunar and Earth Gravitation Conditions 
 
 
Conclusion: These data indicate that when the COM is shifted to the left, there are large 
differences between Lg and Eg conditions. This suggests that NASA should ensure that the COM 
of the PLSS is positioned in line with the sagittal plane for the safety of the astronaut. Although 
an off-center design is not likely, the PLSS could shift during ambulation if it is not securely 
fastened to the pressure garment. 
 
Under simulated lunar conditions, the increase in trunk angle was observed with the COM 
positioned to the back. This is likely a strategy aimed at maintaining balance while preserving 
velocity. Minimal differences were observed between the Lg and Eg conditions for knee angle 
with the COM shifted to the back. These differences are not substantial and would likely have no 
effect on the performance of the mission. 
 
Research Area 2 
Differences in Lower Body Biomechanics in Simulated Lunar and Martian Gravity  
and in Zero Gravity with Bungee Cords 
Purpose: The purpose of this experiment was to measure the lower body biomechanics in 
simulated lunar and Martian conditions, and in zero gravity with bungee cords equal to the lunar 
and Martian gravitational vectors. 
 
Hypothesis: There will be no difference in stride length, knee angle, and hip angle between the 
simulated bungee and actual conditions. 
 
Methods: While walking in a microgravity environment simulated by parabolic flight, 2 test 
subjects were tethered to a treadmill by surgical tubing with a force equal to lunar gravity 
(Lg=1.6 m/s2 BLg ) and Martian gravity (Mg=3.7 m/s2 BMg). These data were compared to the 
gait pattern in actual lunar (L) and Martian (M) conditions created by flight parabolas with 
differing trajectories. 
 
Results: Mean data from the actual and simulated conditions were compared using effect size 
calculations (Cohen’s d). Large effect sizes were observed for stride length in the BLg versus the 
actual L environment (d=1.36). Stride length in MMg and the actual M environment (d=0.92) 
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also demonstrated a large effect size. Minimal effect sizes were BLg for knee angle and that of L 
(d=0.11). When comparing BMg M, small effect sizes were observed (d=0.22). Measurements of 
hip angle for simulated BLg L (d=0.33) showed moderate effect size between conditions. Effect 
size comparisons of hip angle between BMg and M were moderate (d=0.57). 
 
Effect Size Calculations 
Effect size: 0.01-0.29  0.30-0.69   0.70+ 
 
Stride Length 
1/6 versus lunar  1.3613530581585045   Large 
1/3 versus Mars  0.9154434088701604  Large 
Knee Angle 
1/6 versus lunar  0.10938089257489779 Small  
1/3 versus Mars  0.22287100868595375 Small 
Hip/Trunk Angle 
1/6 versus lunar  0.3282243184602572  Medium 
1/3 versus Mars  0.5658896087151467  Medium 
 
 
 
Figure 10. Stride length differences for simulated versus actual lunar and Mars gravity conditions. 
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Figure 11. Knee angle differences for simulated versus actual lunar and Mars gravity conditions. 
 
 
Figure 12. Trunk angle differences for simulated versus actual lunar and Mars gravity conditions. 
 
 98 
Conclusion: These data indicate that gait patterns of stride length are most affected by different 
gravitational pulls. Effect size varied from small to large, depending on the measurement points. 
Small effect size was shown in the stride length. Medium effect size was shown in the trunk angle. 
Large effect size was shown in knee angle measurements. Error in effect size may be due to the 
precision required to calculate the correct weight and tension ratio of the simulated bungee. Sci-
entists should investigate different types of bungee material, or a different method of construction 
should be investigated when developing the bungee weights. A balance of precise calculations 
and superior bungee material will reduce the effect size difference for future studies. 
 
Research Area 3 
Biomechanical Effects of COM Redistribution to Walking Kinematics in  
Bungee Simulated Lunar and Martian Conditions 
Purpose: The purpose of this study was to determine whether CG changes while wearing 
bungees to simulate lunar or martian gravity within a microgravity environment affects lower 
body and trunk biomechanics. 
 
Hypothesis: Movement of CG while wearing the bungees to simulate gravity would have 
minimal effect on lower-extremity biomechanics. 
 
Methods: The mean knee angle, trunk angle, and stride length for the 3 conditions (CCOM, 
LCOM, and BCOM) were compared using effect size calculations (Cohen’s d). 
 
Results: Compared to the CCOM condition, minimal differences were observed in the knee angle 
for BCOM (d=0.05) and LCOM (d=0.16) conditions at bungee simulated Lg. In simulated Mg, 
BCOM (d=0.31) and LCOM (d=0.18) were minimally different. Moderate variations were 
observed in the hip angle for BCOM (d=0.79) and LCOM (d=1.15) for Lg and BCOM (d=0.44) 
and LCOM (d=0.69) for Mg compared to CCOM. Finally, moderate differences were observed 
for stride length at Lg: BCOM (d=0.60) and LCOM (d=0.97) and Mg; BCOM (d=0.90) and 
LCOM (d=0.91). When comparing LCOM to BCOM, the differences were negligible. 
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Figure 13. Stride length with 1/6 bungee. 
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Figure 14. Knee angle with 1/6 bungee. 
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Figure 15. Hip angle with 1/6 bungee. 
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Figure 16. Stride length with 1/3 bungee. 
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Figure 17. Knee angle with 1/3 bungee. 
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Figure 18. Hip angle with 1/3 bungee. 
 
Conclusion: The data suggest that changing the COM of the PLSS under reduced-gravity 
conditions using bungees to simulate lunar and martian gravity alters biomechanics. More 
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research is warranted to determine the biomechanical impact of COM redistribution in these 
unique environmental conditions. 
 
Research Area 4 
Lower-extremity Biomechanics in Zero Gravity with Elastic Resistance 
Purpose: The purpose of this research was to compare the walking kinematics in zero gravity 
using surgical tubing with static forces equal to 1/3 Earth gravity and 1/6 Earth gravity to normal 
walking kinematics on Earth. 
 
Hypothesis: Simulated lunar and Martian gravitational conditions will result in altered 
kinematics compared to normal Earth gravitational conditions. Increases in stride length will also 
result in smaller knee and hip angles. 
 
Methods: Lower-extremity and trunk kinematics were measured using motion-capture software 
(Dartfish). Effect size (Cohen’s d) was calculated to determine differences between conditions. 
Additionally, Pearson’s correlations were calculated to determine relationships between stride 
length and knee and hip angles. 
 
Results: Large variations were observed between knee angles in Eg compared to Lg (d=0.83) and 
Mg (d=0.99). The differences in knee angle between Lg and Mg were negligible. For hip angle, 
large differences existed between Eg and Lg (d=3.40) and Eg and Mg (d=2.88); the differences 
between Mg and Lg (d=0.61) were moderate. Stride length differed between Eg and Lg (d=0.63) 
and Eg and Mg (d=1.16). Moderate differences were also observed between Lg and Mg (d=0.33). 
Stride length correlated poorly to knee (r=0.09) and hip angle in Lg (r=0.22). Moderate 
correlations were present between stride length (r=0.31) and knee and hip angle (r=0.30) in Mg. 
Using surgical tubing to create static forces similar to Lg and Mg significantly changes lower-
extremity kinematics. The differences appear greater during the Mg conditions. Small to negli-
gible differences were observed when comparing the Lg and Mg conditions. The variance ob-
served in knee and hip angle during Lg cannot be explained by a change in stride length. The 
changes in stride length during Mg appear to have a greater impact on knee and hip angle. 
 
Conclusion: Due to the significant changes in biomechanics with surgical tubing, scientists may 
want to explore other methods of tethering the astronaut to the treadmill in zero-G environments. 
 
Research Area 5 
Interrater Reliability of Lower-extremity and Trunk Kinematics Using a  
Two-dimensional Motion Capture Software 
Purpose: Biomechanical analysis is an important subcomponent to understanding human 
performance. Two overall branches of biomechanics are kinematics and kinetics. Kinematics 
describes joint position, displacements, velocities, and acceleration irrespective of force, while 
kinetics measures the forces that cause human movement. To measure kinematics, cameras are 
used to record motion and software quantifies the positions, displacements, velocities, and accel-
erations. Sophisticated systems can calibrate 3-dimensional coordinates of markers in space, but 
they are impractical for many research environments. Dartfish is a 2-dimensional, motion-capture 
software that uses standard video cameras to record movement. It allows the user to analyze 
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performance using built-in measurement tools. However, there may be significant measurement 
error between individual raters. 
 
Hypothesis: Therefore, the purpose of the research was to quantify the inter-rater reliability and 
standard error of mean (SEM) of 2-dimensional motion capture using Dartfish. 
 
Methods: Four raters independently measured the knee and trunk angles and stride length during 
the mid-stance phase of gait in all conditions using Dartfish. These raters entered the data into an 
Excel® spreadsheet and were blinded to the scores of the other 3 raters. After all analyses were 
made, the principal investigator compiled the data into a single spreadsheet. SPSS 16.0 statistical 
software was used to calculate Cronbach’s α on each dependent variable: knee angle, trunk angle, 
and stride length. SEM was calculated for each variable using the test standard deviations and α 
values. The mean knee angles for raters 1, 2, 3, and 4 were 161.04 deg ± 5.75, 161.34 deg ± 6.12, 
161.21deg ± 5.89, and 161.12 deg ± 6.43; respectively. Interrater reliability for knee angle was 
high (α=0.96, SEM=1.48 deg). Minimum trunk angle measurements ranged from 128.6 to 134.5 
deg between raters; the maximum values ranged from 166.6 to 170.6 deg (α=0.94, SEM=1.86 
deg). Stride length measurements were also highly reliable (α=0.99, SEM=0.007 m) between 
rater 1 (0.26 ± 0.08 m), rater 2 (0.27 ± 0.08 m), rater 3 (0.26 ± 0.07 m), and rater 4 (0.26 ± 0.07 
m). 
 
 
Figure 19. Variations of trunk angle measurements between raters. 
 
 
Figure 20. Variations of knee angle measurements between raters. 
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Figure 21. Stride length averages of the raters. 
 
Conclusion: These data suggest that kinematic measurements are highly reliable between raters using 
the Dartfish software. The greater α values for knee and trunk angle were likely due to slight 
differences in the interpretation of the vertex and endpoints of the angles. Using the reported 
SEMs, scientists, and practitioners can be confident that measurement values obtained by 
different individuals are similar. 
 
CONCLUSION 
Flying on the ZERO-G® aircraft provided a unique environment in which to evaluate the effects 
of changing CG on locomotive biomechanics. Several lessons were learned from this experiment. 
Future research should include more test subjects, if possible, to provide a better representation 
of subject variability, and so that statistical evaluations can be conducted. Camera placement is 
critical, and, if possible, future research should ensure that the video camera is placed perpen-
dicular to the sagittal plane of the test subject. 
 
The challenge of returning humans to the moon involves the development of new spacesuit 
systems to enable efficient and effective movement on the lunar surface during EVA. This proj-
ect determined that CG position affects locomotive biomechanics in reduced-gravity environments. 
These preliminary results indicate that it is essential to understand the biomechanical consequences 
of changing the PLSS-CG location to speculate on the potential for injury and/or the rising meta-
bolic demand associated with each CG location. More research is also warranted to determine 
whether locomotive exercise in transit to the Moon and Mars is warranted, and, if so, what 
method of tethering is best to simulate gravitational force. 
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OBJECTIVE 
Evaluate mixing and dispensing steps of new swab system in microgravity (with some additional 
tests in lunar and Martian gravity). 
 
INTRODUCTION  
The Lab-On-a-Chip Applications and Development Portable Test System (LOCAD PTS) was 
launched to the ISS aboard STS-116 on December 9, 2006. 
 
 
 
It has been used aboard the ISS during Expeditions 14 through 18 to monitor bacteria and fungi 
present on cabin surfaces. 
 
 
 
Samples are currently collected from ISS cabin surfaces with the swab system, which consists of 
the swab unit, water cartridge, swab tip, and dispensing tip. 
 
Relevant Low-G Research to Date: KC-135 and C-9 tests between 2003 and 2009 have shown 
that the Lab-On-a-Chip instrument and swabbing/mixing steps function nominally in reduced 
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gravity. The function of all 3 types of LOCAD-PTS cartridge in reduced gravity was verified in 
April 2007. 
 
METHODS AND MATERIALS 
Mixing Tests: Each swab was spiked with 19.5 ng/mL of dye (p-nitroanaline). During zero-G 
onset, the bulb was snapped, water was squeezed down into the swab tube and was mixed during zero 
G for either 5 or 10 seconds. The complete volume of the mixed solution was then evacuated to 
an empty 2-mL Eppendorf tube. The absorbance (at 405 nm wavelength) was then read with a 
nano-drop spectrophotometer to evaluate the mixing efficiency during microgravity. The mixing 
process was videotaped and photographed to document the behavior of fluid within the swab 
tube and the influence of surface tension within the tube, and to determine how these factors 
affect hydration of the swab tip. 
 
Dispensing Tests: These tests were performed to determine the dispensing accuracy of the BULB 
swab tool. They were performed with un-spiked BULB swabs. In hypergravity, the Bulb swab was 
snapped and fluid was squeezed down to the swab tip. At zero-G onset, 4 to 6 droplets were 
dispensed into 200-mL-volume, polymerase-chain reaction (PCR) tubes (see figure 1). The 
BULB swab system was positioned just a few millimeters from the rim of each tube, and each 
droplet adhered to the inside wall of the tube. At hypergravity onset, fluid was pulled down into 
the tube, after which each tube was capped to contain fluid during subsequent parabolas. The 
tubes were stored and the volume measured on the ground following landing. The process was 
repeated in 0.1 G and 0.38 G. All steps were documented by video and photography. 
 
 
Figure 1. Dispensing droplets into PCR tubes during microgravity. Droplets remained in the tubes because of surface 
tension and were capped in hypergravity; the volumes were measured on the ground following landing. 
 
RESULTS 
Figure 2 shows the average volumes of droplets dispensed with the BULB swab system in 1 G 
(black columns), Martian gravity (red columns), lunar gravity (grey column), and microgravity 
(blue column). 
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Figure 2. Effect of gravity level on droplet volume of BULB swab unit. Each column represents the 
average volume of droplets dispensed by the BULB swab unit (error bars = 1 standard deviation). For 
each 1 G, Mars G, and lunar G column, n=6 droplets were dispensed during one parabola. For the zero-
G column, n=150 droplets) were dispensed during 26 separate parabolas. 
 
In addition to gravity level, droplet volumes were dependent on technique used to dispense each 
droplet. For example, the distance between the pipette tip and the surface to which a droplet was 
dispensed (e.g., inner wall of a PCR tube or the cup of a sample well) was critical in determining 
the final droplet volume. 
 
The blue column in figure 2 represents an overall average volume, derived from 150 separately 
dispensed droplets in zero G. These 150 droplets were dispensed in groups of 4 to 6 droplets 
during 26 separate parabolas. The average volume of each group of 4 to 6 droplets is shown in 
figure 3 (with error bar=1 SD). It can be seen from the error bars on each column that the vari-
ation in droplet volume in zero G is greater than in 1 G, but can be minimized, especially with 
the right technique to dispense a droplet at a consistent distance from a surface. 
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Figure 3. Individual average droplet volumes dispensed with the BULB swab unit. Average volumes are 
shown for 1 G (black columns), martian gravity (red columns), lunar gravity (grey columns), and zero G 
(blue columns) with error bar=1 standard deviation. 
 
When a droplet was dispensed far from a surface in zero G, it would grow to almost 10 mm in 
diameter (see figure 4) before detaching by vibration or other forces imparted to the swab unit. 
This “droplet growth” could be prevented if the BULB swab pipette tip was positioned within 2 
mm to 3 mm of the target surface (see figure 5). 
 
Occasionally, the 1-mL volume in the bulb of the swab unit would pool in the upper portion of the 
swab tube, and dispensing would be impossible. This was simply rectified by a downward flick 
to move fluid toward the swab tip. The fluid would then remain at the end of the swab tube (by 
the swab tip) due to surface tension within the swab tube. Dispensing could then proceed. 
 
On other occasions, on removal of the white end cap, fluid would stream out of the tip without 
any manual pressure on the bulb. This may have been due to built-up pressure in the bulb relative 
to the aircraft cabin (maintained around 8,000-feet-equivalent; note that ISS is sea-level-equivalent 
at 14.7 psi). This was rectified by slightly detaching the swab tube and removing that pressure 
differential before removing the white end cap. 
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Figure 4. Droplet dispensed with BULB swab unit  Figure 5. Dispensing droplets into sample wells of a  
in microgravity away from the target surface. LOCAD-PTS cartridge with the BULB swab unit in zero G. 
 Positioning of the pipette tip 2 to 3 mm from the sample  
 well enabled consistent volumes to be dispensed. 
  
 
DISCUSSION 
The BULB swab unit has been proposed to replace the existing swab unit used for LOCAD-
PTS operations aboard the ISS. In many ways, the BULB swab unit is simpler to use, is more 
streamlined, and has the capability to store a sample for later return to the ground and archiving 
at NASA JSC. 
 
The BULB swab unit is a not a micropipette but a dropper-type dispenser. However, it dispenses 
consistent droplets in 1 G (average approximately 30 mL ± 2 mL). The tests performed here in 
microgravity show that, although the variation in droplet volumes increased, it was still within 
fairly narrow bounds (average approximately 30 mL ± 5 mL), which can be accounted for by the 
software in the LOCAD-PTS instrument. 
 
Other issues, such as fluid remaining in the upper part of the swab tube (rectified by a flick) 
and automatic streaming of fluid from the pipette tip (rectified by a swab tube detach to remove 
pressure differential), were solved during each parabolic flight and can be built into future ISS 
procedures, if necessary. Complete mixing was performed in microgravity in fewer than 10 
seconds without much difficulty. 
 
PHOTOGRAPHS 
JSC2009e047900 to JSC2009e047918 
JSC2009e047925 to JSC2009e047943 
 
VIDEO  
• Zero G flight week 2/23–2/27, 2009, Master no.: DV1998 
 
Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
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GOALS 
• Identify appropriate size vial required to withdraw a defined drug volume. 
• Identify hardware that facilitates withdrawal of the appropriate volume of drug from vial 
(various-size blunt cannulas and syringes). 
• Videotape procedure used to withdraw medication from a vial into a syringe for use with on-
orbit procedure. 
 
INTRODUCTION 
The current system for injectable medications aboard the ISS has experienced a materials failure 
that requires a new system for injectable medications to be identified and flown. It is desired that 
this new system will fly medications for injection in their original manufacturer’s packaging. 
This will allow the system to comply with USP guidelines while minimizing the frequency of 
resupply due to medication expiration. However, this change will require crew to draw liquid 
medications for injection from a vial into a syringe prior to injection. 
 
This experiment will evaluate the effectiveness of 2 versions of a blunt cannula to facilitate the 
withdrawal of liquid medication from a medication vial into a syringe for injection within a 
microgravity environment. Other parameters to be assessed include: determining the ability to 
withdraw the required amount of medication and whether this is dependent on vial size, liquid, 
or the total volume of the fluid within the vial. Liquid medications proposed for flight on ISS 
will be used for this experiment. 
 
DISCLAIMER 
The content of this report should not be considered final and binding. Formal review and 
evaluation of all data collected will be the subject of final reports and publications when 
deemed appropriate. The content of this report should permit the reader to become familiar with 
the procedures followed and the preliminary observations and lessons learned. This document 
neither endorses nor rejects the performance of any commercial products used. 
 
Medications for injection are commercially available in a variety of forms, including 
glass/plastic single-dose vials, glass/plastic multi-dose vials, and prefilled syringes. Whenever 
possible, it is desired that injectable medications for use on the ISS be delivered in a prefilled 
syringe to limit the need for astronauts to manipulate the medication prior to administration. 
However, the healthcare market is constantly evolving based on new evidence sources and 
changing standards of care, meaning that medications are not consistently available at the 
desired strengths or volumes in the same packaging over a period of time. 
 
In the event medications must be supplied in a vial, a system is required that allows for the safe 
withdrawal of medication from the vial into a syringe for administration. Traditionally, this 
method of withdrawal requires the use of a needle. In an effort to limit risk of inadvertent needle 
sticks, the healthcare marketplace has a variety of blunt cannulas and vial adaptors that allow di-
rect connection of a syringe to a medication vial, eliminating the need for a sharp to pierce the 
vial septum. 
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Figure 4. Trapping of fluid in medication  
vial due to fluid adhesion. 
 
A November 2008 ZERO-G® flight was used to conduct a hardware evaluation of various 
needleless vial adaptors. The flight evaluation revealed that while the needleless vial adaptors are 
appropriate for use with multi-dose vials, single-dose medication vials with volumes <5 mL pose 
a greater challenge in accessing the entire drug volume required for administration. At issue is the 
manufacturer’s air bubble in the vial. In microgravity, this air bubble traps fluid along the sides 
and base of the vial despite effective air/fluid separation prior to medication withdrawal. Manu-
facturers typically provide some overfill of the vial, but this volume is not predictable. Terrestri-
ally, any fluid that is not immediately at the septum may be “chased” using a needle that can be 
manipulated to the liquid bubble. Both vial adaptors tested limited the ability to chase pockets of 
medication in vial, either due to the locking mechanisms on the vial top or the length of the spike. 
The spike-vial adaptor length was also limiting in vials holding <3 mL of fluid. The spike length 
in relation to where the fluid ports on the spike are was too long to allow access to all of the fluid 
in the vial. Use of single-dose vials without the ability to “chase” fluid risks the possibility of the 
inability to access all of the desired medication from the vial. Thus, this February 2009 flight was 
used to evaluate the effectiveness of blunt cannulas to “chase” the fluid volume in smaller-unit-
dose vials of medications. 
 
Figure 1. Carpuject (current 
method of injectable meds on the 
ISS). 
Figure 2. Single-dose and multi-dose 
medication vials (current method of 
injectable meds on the ISS). 
Figure 3. Commercially prepared  
pre-filled medication syringes. 
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OBJECTIVE 
Identify issues related to withdrawal of liquid medication for injection from a glass medication 
vial into a syringe within a microgravity environment using a blunt cannula. 
 
METHODS AND MATERIALS 
A market survey of blunt cannulas was performed, and 2 primary pieces of hardware were 
selected for further testing. A metal blunt cannula (17 G×1.5 in Kendall MONOJECT) was 
selected for its length as well as diameter, and a plastic blunt cannula (approximately 16 G×0.5 
in, Monoject SmarTip™) was selected as a representative market sample for comparison. 
 
   
 Figure 5. Metal blunt cannula. Figure 6. Plastic blunt cannula. 
 
Hardware testing was completed using the identified blunt cannulas (metal and plastic) as well as 
medications in similar volume and concentration to those currently flown on the ISS. Due to 
delivery delays of the metal blunt cannula, ground-based preflight testing was completed using an 
18 G×1.5-in, metal needle as a substitute. The flight portion of the evaluation was designed to be 
completed within 20 parabolas, lasting approximately 20 seconds each, with testing divided into 
three segments: Segment 1 – fluid withdrawal from vial; Segment 2 – fluid isolation within a 
syringe; Segment 3 – video documentation of procedure steps required to withdraw medication 
from vial into syringe. Two participants were used to conduct all tests. One fixed video camera 
was used to document the experiment. Feedback on each medication and device was captured by 
activated microphones attached to both participants. Materials were immobilized using Velcro® 
and foam blocks for safety during periods of aircraft turbulence and during microgravity portions 
of the flight. Potential sharp objects (e.g., medication vials) were disposed of in a sharps container 
that was attached to the table used in the experiment. Any liquids that were inadvertently released 
during microgravity portions of the flight were captured using towels secured to the work surface. 
Postflight testing using the metal blunt cannula was completed with a smaller-diameter cannula 
due to problems discovered in flight. 
 
RESULTS/DISCUSSION/CONCLUSION 
Based on findings from the November 2008 flight as well as this flight, there are 3 areas of 
discussion for this report: (1) ability to withdraw required amount of medication from vial, (2) 
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air/fluid separation within syringe, and (3) medication characteristics posing issues in 
microgravity. 
 
(1) Withdrawal of medication from vial: Two general areas for discussion were observed during 
this portion of the testing. 
a. Piercing the medication vial septum – Due to a delay in delivery of required hardware, 
ground-based testing of the metal blunt cannula was not possible. A substitution was 
made, and the preflight ground-based testing used an 18 G×1.5-in needle instead. Both the 
needle and the plastic cannula easily pierced through the vial septum in 1-G testing. In 
flight, however, it was discovered that the diameter of the blunt metal cannula caused a 
disruption of fluid at the septum, thus negating the effects of a good fluid/air separation 
maneuver. This, coupled with the short duration of zero-G parabolas (<20 seconds each) 
limited the amount of data collected, as time was spent in zero G trying to re-isolate fluid 
as well as chase fluid from around the vial sides. The plastic blunt cannula performed 
consistently well with septum perforation due to the narrowed tip, which facilitates an 
efficient, non-coring pierce to the septum. 
b. Withdrawal of fluid from the vial – A 1-G evaluation of the hardware revealed that both the 
metal and the plastic blunt cannulas were capable of withdrawing the required volume from 
all of the tested medication vials. It was observed that the metal blunt cannula was able to 
reach the bottom corners of ≤3-mL vials, thus allowing the operator to “chase” the 
medication in all areas within the vial. Due to the short length of the plastic blunt cannula, 
this was not possible. Inflight test results for both pieces of hardware were inconsistent. 
Some medications were better withdrawn with the plastic cannula and others with the 
metal cannula. It is hypothesized that this inconsistency could be attributed to the addi-
tional time required for fluid isolation within the vial due to the challenges mentioned 
above related to spiking the blunt metal cannula as well as the time required to re-isolate fluid 
in the vials used with the blunt plastic cannula due to its shortened length. 
 
           
 Figure 7. Metal blunt cannula in 2-mL vial Figure 8. Plastic blunt cannula in 2-mL vial 
 (cap vial adaptor). (cap vial adaptor). 
 
(2) Air/fluid separation in syringe: Due to dead space within vial adaptors and blunt cannulas, 
despite effective fluid isolation in vial some air will inevitably be mixed into medications as 
they are withdrawn into a syringe. This air, combined with any microbubbles that are possibly 
still in solution, will require a second effort on the part of the astronaut to isolate fluid in the 
Tip of plastic 
blunt cannula 
Tip of metal 
blunt cannula 
 119 
syringe prior to medication administration. Selection of a syringe size larger than the volume 
of medication required is considered to be helpful so that a larger volume than necessary may 
be withdrawn, followed by fluid and air being isolated and then extra air ejected from syringe. 
For this flight, air/fluid separation was evaluated in syringes that were prefilled with a defined 
volume prior to the flight start. It was observed that, when the ratio of fluid-to-volume within 
a syringe increased, the more challenging it was to isolate fluid from air. Given the short dur-
ation of microgravity parabolas, it is hypothesized that repeated attempts at fluid isolation will 
make it possible to achieve sufficient separation no matter what size syringe is used. However, it 
is felt that a larger syringe volume than medication volume should be considered when 
selecting hardware for use with injection. 
 
CONCLUSIONS/RECOMMENDATIONS 
1. Plastic tip and blunt metal cannulas both facilitate the effective removal of medication from 
single-dose medication vials ≤3 mL. However, it is proposed that hardware selected for use 
with single-dose vials ≤3 mL within a microgravity environment have the ability to reach the 
entire interior surface to facilitate “chasing” of medication. This selection will limit the num-
ber of attempts to isolate fluid in vial for one-dose withdrawal, as well as limit repeated 
punctures to the vial septum. 
2. The diameter of the metal blunt cannula was a limiting factor in the microgravity portion of 
this evaluation. It is the investigators’ recommendation that a ground-based evaluation of a 
smaller-diameter blunt cannula be performed to see whether perforation of the vial septum is 
easier. If it is found that this smaller cannula does not facilitate an easier perforation, it would 
be our recommendation that the plastic blunt cannula be flown. 
3. Fluid isolation within a syringe is easier to achieve with a syringe volume that is greater that 
the medication volume. For example, 
a. 1-mL to 2-mL medication volume should use a ≥3-mL syringe. 
b. 3-mL medication volume should use a ≥5-mL syringe. 
c. ≥4-mL medication volume should use a ≥10-mL syringe. 
 
Limitations of evaluation: 
1. Parabola length was too short to evaluate all of the steps required to withdraw medications 
from a vial, taking into consideration fluid bubble management. These steps are required in 
full sequence in microgravity to fully assess the time impact required to withdraw the 
medications. 
2. Bubbles and microbubbles that could be formed during the agitation of launch and subse-
quent continuous microgravity could not be realized in this study due to the aircraft pullouts. 
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GOAL 
This University of Kentucky experiment dealt with the development and design for the next-
generation EVA suits for Constellation missions to the Moon. The Human Research Program is 
currently conducting preliminary studies to examine feasibility issues associated with extended 
continuous use of EVA suits of up to 144 hours. The purpose of this study is to determine how to 
handle an emergency situation that would occur if the spacecraft cabin atmosphere becomes 
unsuitable to sustain life. 
 
A partial or complete loss of cabin pressure could cause a spacecraft fire, which could render the 
cabin atmosphere incompatible with life. In the event that an emergency does occur, the 
astronauts will need medication. The purpose of this experiment is to determine how it would be 
possible to deliver medications to the astronauts. This is important because an injury could occur 
during the extended duration within the suit. There are multiple microgravity issues such as 
dosage preparation, penetration of the syringe needle through the suit portal, foreign objects within 
the syringe needle, and targeting the appropriate tissue for injection. It is important to move the 
air bubble in the syringe to the top of the syringe so that it will not cause harm to the astronauts. If 
it is not moved out of the syringe, air embolism can occur. Air embolism, which is a medical 
condition caused by gas bubbles in the bloodstream, can cause death if a gas bubble becomes lodged 
in the heart and stops blood flow. 
 
OBJECTIVES 
The University of Kentucky’s main objectives with this experiment were to see movement of the 
bubble in all the syringes, the bubble moved to the top of the syringe, which speed (rpm) worked 
better for the movement of the bubble, and how the small and large bubbles moved in the 
different syringe sizes. 
 
METHODS AND MATERIALS 
The University of Kentucky’s research began with internet research to gain a better understand-
ing of the experiment problem. The team also worked with the assigned NASA mentor to grasp 
an idea of what was expected to obtain successful data. Once a good understanding of the experi-
ment was obtained, the team consulted with our University of Kentucky mentor and various Uni-
versity of Kentucky professors to talk through design ideas. Talking with the assigned NASA 
mentor, University of Kentucky mentor, and University of Kentucky professors was very helpful 
because the team was then able to begin sketching and modeling preliminary designs for the 
experiment. 
 
After running through many preliminary designs, one design was decided on. This design uses a 
rotating aluminum shaft with 2 steel circular disks driven by a stepper motor. The first circular 
disk contains 0.5-mL, 1-mL, 3-mL, 6-mL, and 10-mL syringes of water and glycerin that are set at a 
15-degree angle from the horizontal. The second circular disk, which is placed directly above 
the disk with the syringes, has 4 digital video cameras to record the movement of the bubbles 
in the syringes. Each of the syringes is filled with food coloring and either a large or small 
bubble size. Table 1 describes this labeling system. The shaft and disks are all completely 
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enclosed in a Plexiglas® box that is mounted on a metal rack that was provided by our NASA 
mentor. 
 
Table 1 
Parabola Rate 
Syringe 
Size Syringe Content 
1 (1) Slow 10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
2 (2) Fast 10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
3 (3) Fast-Stop 10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
4 (4) Medium 10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
5 (5) Slow-Stop 10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
6 (6) Medium-
Stop 
10 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
7 (1) Slow 0.5 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
8 (2) Fast 0.5 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
9 (3) Fast-Stop 0.5 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
10 (4) Medium 0.5 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
11 (5) Slow-Stop 0.5 ml Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
12 (6) Medium-
Stop 
0.5 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
13 (1) Slow 3 ml Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
14 (2) Fast 3 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
15 (3) Fast-Stop 3 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
16 (4) Medium 3 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
17 (5) Slow-Stop 3 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
18 (6) Medium-
Stop 
3 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
19 (1) Slow 1 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
20 (2) Fast 1 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
21 (3) Fast-Stop 1 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
22 (4) Medium 1 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
23 (5) Slow-Stop 1 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
24 (6) Medium- 1 mL Big – Water Small – Big – Small – 
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Table 1 
Parabola Rate 
Syringe 
Size Syringe Content 
Stop Water Glycerin Glycerin 
25 (1) Slow 6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
26 (2) Fast 6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
27 (3) Fast-Stop 6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
28 (4) Medium 6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
29 (5) Slow-Stop 6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
30 (6) Medium-
Stop 
6 mL Big – Water Small – 
Water 
Big – 
Glycerin 
Small – 
Glycerin 
 
 
 
Illustration of the test rig. 
 
After researching and constructing the design, the University of Kentucky team made hypotheses 
about the experiment. These hypotheses were as follows: 
 
• If an astronaut flicks his or her wrist quickly, the bubble will move. 
• If the syringes are spun at fast speeds on the disks, the bubble will move. 
 
RESULTS 
The air bubble was observed to move with certain combinations of syringe diameter, fluid 
viscosity, and rotation speed. Bubble motion was recorded at all 3 rotation speeds in the second 
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flight. These speeds were 26 rpm, 44 rpm, and 54 rpm. In the first flight, the rotation speeds of 6 
rpm, 16 rpm, and 26 rpm yielded no bubble movement. While 26 rpm was evaluated in both 
flights, movement was observed only in the second flight due to an increase in rotation duration 
from the first flight. The increase of 5 seconds in the rotation time allowed for an increase in 
momentum sufficient to move the air bubble. 
 
The tables and graphs below show the results for the various syringes for both flight days. 
 
Water – Big Bubble 
Slow 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
  0.5 0.5 0.5 0 No 
  1 1 1 0 No 
  3 2.4 0.7 1.7 No 
  6 No Data No Data No Data -- 
  10 No Data No Data No Data -- 
 
Fast 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
  0.5 0.5 0.5 0 No 
  1 1 1 0 No 
  3 2.4 0 2.4 Yes 
  6 No Data No Data No Data -- 
  10 7.4 0 7.4 Yes 
 
Fast-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 No Data No Data No Data -- 
 6 3.8 0 3.8 Yes 
 10 7.3 0 7.3 Yes 
 
Medium 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.3 0 2.3 Yes 
 6 3.8 0 3.8 Yes 
 10 7.4 0 7.4 Yes 
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Slow-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.4 1.3 1.1 No 
 6 3.8 0 3.8 Yes 
 10 7.5 0 7.5 Yes 
 
Medium- 
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
  0.5 0.5 0.5 0 No 
  1 1 1 0 No 
  3 2.4 1.3 1.1 No 
  6 3.8 0 1.3 Yes 
  10 7.4 0 7.4 Yes 
 
Water – Small Bubble 
Slow 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 3 3 0 No 
 6 No Data No Data No Data -- 
 10 No Data No Data No Data -- 
 
Fast 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 2.4 0 2.4 Yes 
 6 No Data No Data No Data -- 
 10 7.4 0 7.4 Yes 
 
Fast-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 No Data No Data No Data -- 
 6 4.8 0 4.8 Yes 
 10 7.4 0 7.4 Yes 
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Medium 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 3 3 0 No 
 6 4.8 0 4.8 Yes 
 10 7.4 0 7.4 Yes 
 
Slow-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 3 3 0 No 
 6 4.8 0 4.8 Yes 
 10 7.4 0 7.4 Yes 
 
Medium- 
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 3 3 0 No 
 6 4.8 0 4.8 Yes 
 10 7.4 0 7.4 Yes 
 
Glycerin – Big Bubble 
Slow 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.5 2.2 0.3 No 
 6 No Data No Data No Data -- 
 10 No Data No Data No Data -- 
 
Fast 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.5 1.2 1.3 No 
 6 No Data No Data No Data -- 
 10 5.8 0 5.8 Yes 
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Fast-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 No Data No Data No Data -- 
 6 4 2.8 1.2 No 
 10 5.8 2.8 3 No 
 
Medium 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.5 1.7 0.8 No 
 6 4 0.6 3.4 No 
 10 5.8 0 5.8 Yes 
 
Slow-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.5 1.9 0.6 No 
 6 4 3.4 0.6 No 
 10 5.8 3.2 2.6 No 
 
Medium- 
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 2.5 1.8 0.7 No 
 6 4 3 1 No 
 10 5.8 3.2 2.6 No 
 
Glycerin – Small Bubble 
Slow 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.4 2.2 0.2 No 
 6 No Data No Data No Data -- 
 10 No Data No Data No Data -- 
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Fast 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.4 1.2 1.2 No 
 6 No Data No Data No Data -- 
 10 6.4 0 6.4 Yes 
 
Fast-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 No Data No Data No Data -- 
 6 4.6 3.6 1 No 
 10 6.4 2.6 3.8 No 
 
Medium 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 No Data No Data No Data -- 
 3 3.2 1.8 0.6 No 
 6 4.6 3.5 1.1 No 
 10 6.6 0 6.6 Yes 
 
Slow-
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all  
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.4 2.2 0.2 No 
 6 4.6 3.8 0.8 No 
 10 6.8 4 2.8 No 
 
Medium- 
Stop 
Syringe Volume 
(mL) 
Start Location 
(mL) 
Final Location 
(mL) 
Displacement 
(mL) 
Did bubble move all 
the way to the needle? 
 0.5 0.5 0.5 0 No 
 1 1 1 0 No 
 3 2.4 2.3 0.1 No 
 6 4.5 0.4 4.1 No 
 10 6.8 4 2.8 No 
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*See Appendix for conversion from mL to in. 
**Results with no data are given a value of 0 on graphs. 
 
The force acting at the center of the syringes increases with rotation speed. The G-forces acting 
on the syringes for each of the tested rpm’s are: 
 
0.0026 Gs for 6 rpm 
0.0070 Gs for 16 rpm 
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0.0113 Gs for 26 rpm 
0.0192 Gs for 44 rpm 
0.0235 Gs for 54 rpm 
 
These G-forces were found using the following equation: 
 
G = (1.118 × 10–5) R S2 
 
where G is the G-force created by the centrifugal force, R is the radius of the rotor in centimeters, 
and S is the rpm’s at which the syringe was rotated. 
 
The following is a sample calculation of the G-force acting on a syringe rotating at 26 rpm: 
 
S = 26 rpm 
R = 2.5 in * (2.54cm/ 1in) = 6.35cm 
G = (1.118 ×10–5) (26 rpm) (6.35cm)2 
G = 0.0117 Gs 
 
Due to the fact that the syringes were placed on wedges, the component of the G-force, which 
acts in the direction of the syringe, must be calculated as follows: 
 
c = gcos15º 
 
where c is the component of the G-force that acts in the direction of the syringe and g is still the 
G-force created by the centrifugal force. 
 
c = gcos15º 
c = 0.0113 Gs 
 
DISCUSSION 
This experiment provided many challenging opportunities for the team members involved. The 
proper alignment of the shaft in the bearings proved to be quite problematic. We were unable to 
acquire the highly accurate measuring tools required to gain the precise alignment necessary for 
the bearings. Without the proper alignment the bearings were unable to reduce the friction enough 
to allow for shaft movement. Using the tools we had access to, we secured the bearings in as close 
to the correct alignment as possible. Because we could not find the perfect alignment, there was a 
slight wobble in the shaft. To stop the shaft from wobbling, the motor had to be allowed to wobble. 
The challenge we faced was finding a way to secure the motor but still allow for it to wobble. We 
solved the problem of securing the motor by using a vice clamp. The clamp secured the motor in 
place while allowing enough movement in the motor to correct the wobble in the shaft. 
 
Another challenge we encountered was the proper propositioning of the air bubble. To observe 
the effects of the centrifugal forces on the air bubble, the bubble had to begin at the end of the 
syringe that was furthest from the center of rotation. To solve this problem, the syringes were 
placed on wedges. The incline of the wedges allowed the bubble to be forced to the top of the 
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syringe when gravity acted on the fluid in the syringe. This solution effectively allowed the 
bubble to preposition automatically between each parabola. 
 
CONCLUSION 
As can be seen from the graphs and charts on the previous pages, the bubble moved in the larger-
size syringes, which were the 3-mL, 6-mL, and10-mL syringes. There was very little movement 
in the 0.5-mL and 1-mL syringes. The bubble also moved more easily in water than in glycerin. 
The medium to fast speeds moved the bubble the most in the syringes. For the slower speeds, the 
bubble did not move. For water, the big bubble and the small bubble were very similar 
displacement wise. The displacement in glycerin of the big bubble and the small bubble was also 
very similar. 
 
APPENDIX 
The dimensions of the 6 tested syringes are as follows: 
 
Volume 
(mL) 
Diameter 
(mm) 
Diameter 
(in) 
Length 
(in) 
Number of 
tick marks on 
each syringe 
Distance 
between each 
tick mark (in) 
Number of inches 
corresponding to 
1 mL on the 
syringe 
0.5 4.64 0.18 1.16 50 0.023 2.33 
1 4.78 0.19 2.19 100 0.022 2.19 
3 8.66 0.34 2.01 30 0.067 0.67 
6 12.7 0.50 1.86 30 0.062 0.31 
10 14.5 0.57 2.38 50 0.048 0.24 
 
The last column of the table above can be used to convert the displaced volume to the actual 
distance the bubble moved in the syringe. 
 
PHOTOGRAPHS 
JSC2009E070199 to JSC2009E0070202 
JSC2009E070224 
JSC2009E 070298 
JSC2009E070339 
JSC2009E070342 
JSC2009E070349 
JSC2009E070351 
JSC2009E070353 
JSC2009E070354 
JSC2009E070372 
JSC2009E070373 
 
VIDEO 
• Zero-G flight week 3/30–4/03/09, Master no.: DV2062 
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Videos are available from the Imagery and Publications Office (GS4), NASA JSC. 
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Appendix 
 
 A-2 
 
Background Information about the C-9 and the Reduced Gravity Program 
 
The Reduced Gravity Program, operated by NASA JSC, provides engineers, scientists, and 
astronauts alike a unique opportunity to perform testing and training in a weightless environment 
without ever having to leave the confines of the Earth’s orbit. Given the frequency of space shuttle 
missions and the construction and habitation of the new ISS, the Reduced Gravity Program 
provides a truly ideal environment in which to test and evaluate space hardware and experimental 
procedures prior to launch. 
 
The Reduced Gravity Program was established in 1959 to investigate the reactions of humans and 
hardware during operations in a weightless environment. A specially modified turbojet, flying 
parabolic arcs, produces periodic episodes of weightlessness lasting 20 seconds to 25 seconds. 
The aircraft is sometimes also flown to provide short periods of lunar (1/6) and Martian (1/3) 
gravity. Over the last 50 years, more than 100,000 parabolas have been flown in support of 
Project Mercury and the Gemini, Apollo, Skylab, Space Shuttle, and International Space Station 
Programs. 
 
Excluding the C-9 flight crew and the Reduced Gravity Program test directors, the NASA C-9 
aircraft accommodates seating for a maximum of 20 other passengers. The C-9 cargo bay 
provides a test area that is approximately 45-ft long, 104-in wide, and 80-in high. 
 
NASA has also recently transitioned to using the ZERO-G 727 aircraft, which will hold up to 
30 investigators. The ZERO-G 727 is nearly identical in size and volume to the KC-135 aircraft 
that was previously used by NASA to support the Reduced Gravity Program. This Boeing 727 
has a larger cargo door to accommodate large payloads and provides a test area that is 
approximately 70 ft long, 140 in wide, and 86 in high. 
 
Both aircraft are equipped with electrical power for test equipment and photographic lights. 
When requested, professional photography and video support can be scheduled to document 
activities in flight. 
 
A typical flight lasts 2 hours to 3 hours and consists of 30 parabolas to 40 parabolas. The 
parabolas are flown in succession or with short breaks between maneuvers to allow time for 
reconfiguration of test equipment. 
 
For additional information concerning flight weeks sponsored by the JSC Human Adaptation and 
Countermeasures Division or other Reduced Gravity Program opportunities, please contact: 
 
Todd Schlegel, M.D. Dominic Del Rosso 
Technical Monitor, Human Adaptation Test Director 
and Countermeasures Division NASA Lyndon B. Johnson Space Center 
NASA Lyndon B. Johnson Space Center Reduced Gravity Office, Ellington Field 
Mail Code: SK Mail Code: CC43 
Houston, TX 77058 Houston, TX 77034 
Telephone: 281-483-9643 Telephone: 281-244-9113 
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Explore the Zero-Gravity Experiments and Aircraft Operations Web pages at: 
http://zerog.jsc.nasa.gov/ 
http://jsc-aircraft-ops.jsc.nasa.gov 
 
